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Investigation of coordination and n-stacking interactions with ferriprotoporphyrin IX 
(Fe{III)PPIX) using a fragment approach was undertaken in order to propose and synthesise 
novel compounds which followed a hypothesised mechanism of action to inhibit ~-haematin 
formation. Coordination of a series of pyridines, imidazoles, amines and phenolates with 
Fe{III)PPIX, and n-stacking interactions of these compounds with protoporphyrin IX (PPIX) and 
Fe(III)PPIX were measured in 40% (v/v) aq. DMSO by spectrophotometric titration. The 
calculated pH independent log association constants for coordination (log Kc) in this solvent 
system were found to exhibit a linear free energy relationship (lFER) with the pKa of the ligand 
donor atom. This relationship was confirmed for observed association constants under non-
aqueous conditions (20% (v/v) DMSO in methanol). Calculated log Kc, cak values under acidic 
aqueous conditions (pH 4.8) are predicted to be extremely weak. Association arising from 
n-stacking interactions (log Ks) with PPIX and Fe(III)PPIX was found to strengthen with an 
increase in the number of n-electrons in the aromatic ring system. It was observed that 
Fe{III)PPIX has a log Ks which is on average 0.57 log units lower than with PPIX. Association 
constants of compounds that can coordinate and n-stack were found to be the sum of log Kc,obs 
and log Ks. This allows for the prediction of association constants (log Kcalc) with Fe{III)PPIX for a 
variety of compounds, provided their pKa values are known. Using the derived prediction 
equation, 9-hydroxyfluorene was identified as a scaffold compound with a relatively strong 
Fe(III)PPIX association (log Kobs = 3.64 ± 0.09 at pH 7.4,40% aq. DMSO). Guanidine, amine and 
l,3,S-azaadamantane hydrogen bonding moieties were identified as being suitable for 
incorporation into the scaffold molecule through a one or two carbon linker at the 9-position of 
the fluorene ring system to provide five proposed compounds for inhibition of ~-haematin 
(synthetic haemozoin) formation. These five compounds were 9-{2-aminoethyl)-fluoren-9-01 (A); 
1-[2-{9-hydroxy-fluoren-9-yl)ethyl]guanidine (B); 9-{aminomethyl)-fluoren-9-01 (C); 1-[(9-
hydroxy-fluoren-9-yl)methyl]guanidine (O) and 9-{l,3,5-triazatricyclo[3.3.1. 13, 7] dec-7-
ylmethyl)-fluoren-9-01 (E). Compounds A, B, C and 0 were successfully synthesised but isolation 












Synthesis of compounds A - 0 began with a Corey epoxidation of 9-fluorenone, giving the 
spiro[fluorene-9,2 1-oxirane] epoxide which underwent ring opening upon nucleophilic attack by 
sodium cyanide and subsequent reduction with lithium aluminium hydride produced 
compound A. Compound B was obtained as a nitrate salt through guanylation of compound A 
using the guanylating agent 3,S-dimethylpyrazole-l-carboxamidine nitrate (OPCN). Compound 
C was obtained via a Staudinger reduction of 9-(azidomethyl)-f1uoren-9-0I, produced from the 
ring opening of spiro[fluorene-9,21-oxirane] by sodium azide. Compound 0 was produced by 
guanylation of compound C using OPCN but low yields and large amounts of by-product 
formation prevented isolation. Compounds A, B, C and 9-hydroxyfJuorene were tested for 
p-haematin inhibition, however, none showed any activity towards preventing formation at 200 
equivalents (67 equivalents in the case of compound C owing to lack of solubility). This was 
expected for 9-hydroxyfJuorene owing to the lack of a hydrogen bonding moiety as well as for 
compounds A and C. Modelling indicated the hydrogen bonding group of compound A was 
directed away from the propionate side chain and compound C had too short a linker length to 
provide favourable hydrogen bonding interactions with the propionate side chain. The lack of 
inhibition was initially unexpected for compound B. Association constants of the synthesised 
compounds were found to be lower than that of the scaffold compound, indicating that 
substitution at the 9-position of 9-hydroxyfluorene had a negative effect on Fe(III)PPIX 
association. It was found using a pKa prediction program (MOKA) that the substitution at this 
position probably causes an increase in the predicted pKa of the hydroxyl moiety which results 
in a lowered affinity for coordination to Fe(III)PPIX owing to its increased proton competition 
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CHAPTER 1. INTRODUCTION 
1.1 Malaria 
Malaria has had a long history as a disease, with records of its occurrence dating back to the 
times of classical Rome. 1 It has been closely associated with marshes and in fact, the name 
malaria stems from the Italian phrase "mal'aria" meaning "bad air,, 2 It has continued to make 
its presence felt in the modern world with between 350 to 500 million reported clinical cases 
and over 1 million deaths annually, th e majority of which are children under five years of age 3 ,4 
Globally, malaria is predominantly encountered in the tropical and subtropical regions (see 
figure 1.1) with roughly 80% of malaria cases occur in sub-Saharan Africa. 3 
",. Iori •• """"""'I~ 
_ v",y •• go 
_ >f'9~ 
_ "","r .. ~ 
C La-' , 
Figure. 1.1. Global distribution of malaria t ransmission . Reproduced from reference 5 
The spread of th e disease is r ife in t he sub-Saharan African countries where a large majority of 
the population live in rura l areas, allowing for more frequent contact between the human host 










CHAPTER 1. INTRODUCTION 
1.2 Parasite life cycle 
Malaria is caused by five species of the parasite Plasmodium, with the most dangerous being P. 
!a!ciparum and to a much lesser extent P. vivax.2. 4 P. malariae and P. ovale are less common 
than the former two and more recently P. knowlesi, the species found to cause malaria in 
rhesus monkeys, has been discovered in the human population in South East Asia? While all 
species are found in the tropics and subtropics, P. vivax is also able to survive in the vector 
mosquito at lower temperatures and thus can occur further away in more temperate areas. 6 
The parasite has a complex life cycle (illustrated in figure 1.2) consisting of three stages, 
however, the symptoms of malaria only become apparent in the blood stage. 2• S 
Figure 1.2. Life cycle of the malaria parasite, Plosmodium Figure reproduced from reference 6. 
The malaria parasite enters the human host blood stream in the form of sporozoites via the 
salivary glands of an infected female Anopheles mosquito. 2 The sporozo ites migrate to the liver 
where they invade hepatic cells and undergo asexual fission forming a cyst- li ke structure known 
as a liver schizont. 2. i> During this reproductive period, lasting five to twenty five days depending 
on the specie s, the host remains free of malaria symptoms.2 Inside the liver schizont, the 
sporozoites deve lop into merozoites which are released into the blood stream when the liver 










CHAPTER 1. INTRODUCTION 
Up until this point, the parasite is said to be in the liver stage. The merozoites then invade red 
blood cells (RBCs) to begin the blood stage. Once inside the RBC, the parasite utilises the 
haemoglobin present as an energy source providing for its growth into a trophozoite, before 
developing into a blood schizont. Once this schizont eventually ruptures, six to twenty four 
parasites are released and infect further RBCs, beginning another blood cycle.6 One blood cycle 
occurs every 48 to 72 hours, depending on the species, and increases the parasite load by 
roughly 8- to 10- fold in P. !alciparum.s, 6 The release of the parasite, toxins and RBC debris 
caused by the ruptured blood schizonts results in the symptoms of malaria, namely fever and 
chills, becoming apparent.2, 6 Certain parasites within the RBCs develop into sexually mature 
male and female forms termed gametocytes. Once a female Anopheles mosquito feeds on an 
infected human host's blood, the gametocytes undergo sexual reproduction to produce 
oocysts, which then release sporozoites that migrate to the salivary glands, completing the 
parasitic life cycle. 2 
The control of this disease largely focuses on control of vector mosquitoes, use of bed nets and 
the use of antimalarial drug therapies to reduce and eradicate the parasitaemia load in infected 
persons. Prophylaxis, in the case of travellers is also of importance.9 
1.3 Antimalarial drug tareets 
Antimalarial drugs act on the different stages of the parasite life cycle but the majority are 
active in the blood stage. Drugs acting on this stage can be divided into thrt!e broad categories: 
(i) nucleic acid inhibitors; (iii) oxidative stress inducers/Ca2+ATPase inhibitors and (iii) haem 
detoxification inhibitors. 10, 11 Table 1.1 summarises the various classes and their modes of ' 
action albeit the mechanisms through which some of them assert their antimalarial activity are 











CHAPTER 1. INTRODUCTION 
Table 1.1. Summary of antimalarials and their targets in the blood stage of the malaria parasite. 
Pathway Drug Class Antimalarial Examples Mode of Action 
Nucleic acid Folate antagonists Sulfadoxine Inhibition of parasitic enzymes involved 
inhibitors Pyrimethamine in folate metabolism which are 
responsible for the synthesis of parasitic 
pyrimidines and are essential for DNA 
production.l0,11 
Naphthoquinones Atovaquone Uncouples electron transport in the 
mitochondrion, causing a collapse in the 
organellar membrane potential 
preventing the regeneration of 
ubiquinone, an electron acceptor for 
dihydroorotate dehydrogenase which in 
turn is an essential enzyme for 
pyrimidine biosynthesis.11, 12 
Oxidative stress Endoperoxides Artemesinin The mode of action of artemesinin is of 
inducers/Ca2+ ATPase debate in the literature. Two main 
inhibitors processes have been proposed: 
(1) Inhibition of SERCA 
(Sarco/Endoplasmic Reticulum Ca2+ -
ATPase) orthologue protein PfATP6 after 
activation by Fe(lI) through cleavage of 
the artemesinin endoperoxide bridge.
13 
(2) Formation of radicals by reaction with 
Fe(II)PPIX can lead to the alkylation or 
hydroxylation of biomolecules and thus 
pa rasitic death .10 
Haem detoxification 4-Aminoquinolines Chloroquine Inhibition of detoxification of haem, 
inhibitors Amodiaquine produced as a by product of 
haemoglobin degradation, leads to 
parasitic lipid peroxidation and thus 
death. 14-16 
Aryl-amino Quinine Various modes of action have been 
quinolines Halofantrine proposed, including that of inhibition of 
Mefloquine haem detoxification. Disruption of 
essential metabolite membrane 
trafficking has also been proposed for 
mefloquine.17-19 
Of the three broad categories, antimalarial compounds that are active through inhibition of . 
haem detoxification are of particular interest owing to the fact that some of the most 











CHAPTER 1. INTROOUCnCJN 
1.4 H~emoglobin degradation by the parasite 
During the blood stage of the malaria parasit~ life cycle (s~e s~ct i on 1.2), in ord~r for the 
parasit~ to be ab le to survive in the harsh conditions ofthe RBC, it needs to degrade t he oxygen 
carrying protein haemoglobin (Hb) into peptides essentia l for nutrition.?O Once P. !olciporum, in 
th e meroziote stage, has invaded the red blood ce ll, it engu lfs a large quantity of haemoglobin 
in a process termed the "Big Gulp ' by El liott et al." This produces a ha~moglobin containing 
vacuole which has been proposed to form the ac idic digestive vacuole of the parasite. " In the 
trophozoite stage, 60 to 70"% of the haemoglobin present in the RBC is said to b~ ing~sted 
through transportation by ~ ndocytotic vesicl es, created from the paraSitic plasma membran e. 
to the acidic digestive vacuole,"''' Studies est imate the pH of th is diRestiv~ vacuol~ to be 
approx. 4.8 - 5.4. '" '" Once in the digestive vacuole, degradation of the haemoglobin into 
pep tides is facilitated by proteolytic enzymes which include th e (i) aspartic proteases 
plasmepsin I, II and IV and histo-aspartic protease, (ii) cyste ine proteases falcipain 1, 2 and 3, 
and (iii) zinc metalloprotease facilysinu ]<J Further degradation of t he pept ldes into amino acids 
is accomplished by hydrolysis which takes place in the parasitic cytosol (summar ised in figu re 
1.3)." 
Fi~ur~ 1.3. ~ ' UC"." of hJ~mGglooin (H b) de~radatio n and ,ub,eqllent detoxification of F€ ( I I I )rrl~ (hae""tin) by 











CHAPTfR 1. INTRODUCTION 
As a consequence of haemoglobin degradation, a large amount of haem (ferroprotoporphyrin 
IX. Fe(II)PPIX) is released ~s a by-product wh ich is rap idly and ir reversibly oxidised to h~ematin 
(hydroxojolquo-fer riprotoporphyrin IX, HO jH,O·Ff'( llIjPP IXj, thf' structurf' of which (excluding 
the ~x i ~1 flO/H ,O li g~nd ) is ill \ J str~ted in figure 14a " Fe(III)PPIX pre5ent in sLKh I ~rse 
qu~n tities is toxic to the paras ite, mokin g J noturol detoxificat ion process necessolry. ·'·' lhis 
process involves t he dimeris~tion of Fe(I II)PP IX wh ereby one propionate of each monomer 
(oordin~tes to the iron centre of the other. The second propionic ac id group of each Fe(lll)PPIX 
hydrogen bonds to a neighbouring dimer to form highly insoluble crystals known as haemoIOin 
(see figure lAb for structure).'" It h~s been shown th~t at lea st 95% of h~em is detoxified 





Figure 1.4. I.) The ,trLJ,tur~ of ferr iprotopo rphyrin IX. Fe(I II)PPIX, excl ud in r, the " i, 1 HO"/ H, O li ~,nd lor d.,i!y 
(b) T h. 'tructure of hilcmo,oin wn.,i,ts 01 , Fe(III)PPIX dimer where the propio"'t~ side , h,in is coo rdin. ted to 
lhe iron cent,. 01 the ether . Hydrogen bonding Id"hed line,) 0"''' ' between the· f",,, propKln.le< e l 










CHAPTER 1. INrRODUCTION 
1.5 Haemoloin formation 
There has been much controversy in the li terature over the mechanism by which haemozoin 
forms with many authors such as Sullivan and co worke rs 35 initia lly sugge stinB the invo lvemC'nt 
of histidine-rich protein II. On the other hand, Dorn et 01.35 showed t hat formation could be 
governed by an autocatalytic process, whilC' a further mechanism was proposed by Bendrat et 
01.37 where formation was observed to involve lip ids. Recent evidence seC'ms to lend support to 
the idea of lipid involvement in haemozoin formation with Coppens and Vielemayer~8 having 
observed haemozoin crystals encapsulated in lipid drop lets within the acidic diBestive vacuole 
and later by Pisciotta et 01 .39 who demonstrated that haemozoin occurs with in neut ral lipid 
nanospheres (see figure 1.5). A similar discovery wa s made by Oliveri a and co-worke rs40 in the 
helminth worm, Schistosoma mansoni, and while this parasite is not a re lative of Plasmodium, 
the finding supports the possibility that haemozoin formation occurs universally in close 
contact with lipids. 
Figure 1.5. Transmission eleetror. m l erogr~ph (TE M) i m~ges of e~rly st~ge and mature (II ~nd B) P. [a/cjparum 
trophozoites. Insets. Haemozoin enc~psulated in lipid n~nospheres . Scan ning electron micrograph (SEM) images 











CiMPTfR 1. iNTROOUCTION 
Add i tion~1 s~pport for th is formation process has also been described bv Ega n et ai," where 
the formation of >vnthet ic h~emOlo i n, known ~s B-h~em~tin, occurs very efficiently Jt 
lipid/w ater interfaces under physio logicJ I conditions. Th£' id£,ntificJtion of the spontan£'ou> 
formJtion of d fHl F£,( II I)PPIX dimer >pecies in ~queous so lut ion bv de V il liers et 01." using UV-
vis spect roscopy ~nd NMR spectrometry ~s well as computationa l investigations bV Egan et al." 
indicating spontJn£'ous formation of a haemo'oin dimer precursor from the 1\-1'[ di mer also 
strongly support the v~ l id i tv of this proposed mechanism offormation (see fig~re 1,6). 
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Fi8ure 1.6. (oi Sponl""eou< convOf~ o n of the T'[ T'[ dim~r of F~ IIIJ PPIX in ," ,ULJm (ii to . h""m<)lOin prNCursor 
dimer (iii, In 'Queous solut ion th i. peecur""r rp'Prt> to a" " dim~r, indbtin~ that formation of thP precu"or i, 
unli~e~ in ,n 'Queous enoi ronme,, \. ib) form;,tion of h'~molOin from thP p r~r. LJ "or dimer whPr~ [Oordin.tion 











CHAPTER 1. INTRODUCTION 
1.6 Inhibition of haemozoln by antimalarials 
As mentioned in section 1.3, several classes of drugs are reported to act against haemozoin 
formation, with the family of quinoline derivatives and related compounds the most important. 
The reason for the importance is the potent antimalarial activity and widespread clinical use of 
members of this family including such drugs as chloroquine (CQ), mefloquine {Mf) and 
halofantrine (Hf, structures shown in figure 1.7). The ability of chloroquine and related 
compounds to inhibit l3-haematin formation has been previously reported and these 
I3-haematin activities correlate with their corresponding in vivo activity, lending support to their 





~c3 ill CI 0 ~ CI 
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CQ Mf Hf 
Figure 1.7. Structures of antimalarials chloroquine (CQ), mefloquine (Mf) and halofantrine (Hf). 
Chloroquine has been referred to as one of the most successful antimalarials ever developed 
because of its effectiveness, safety and low cost.45 Following the appearance of chloroquine 
r.esistant parasites, it has been necessary to turn to a variety of drugs of similar structure, such 
as mefloquine and halofantrine, to combat malaria. More recently, artemisinin combination 
therapy has been the treatment of choice, but this also invariably involves a quinoline or 
related compound such as mefloquine, amodiaquine or lumefantrine.46, 47 In addition to the .. 
emergence of resistant parasitic strains, the mechanism of action by which chloroquine and 











CHAPTER 1. INTRODUCTION 
1.7 Antimalarial drug resistance 
Resistance to antimalarial drugs, especially chloroquine, have been the attributed as the main 
cause in the rising morbidity and mortality rates for malaria.48 While the use of artemesinin 
combination therapy has helped alleviate this disease to some extent, there have been reports 
of sporadic decreased sensitivity to this treatment and evidence seems to suggest resistant 
strains are emerging.49-51 In order to propose novel antimalarial compounds which are effective 
against both sensitive and resistant strains, knowledge of how parasites become resistant to 
antimalarial drugs is of importance. 
1.7.1 Mechanism of chloroquine r.esistance. 
It has long been known that resistance to chloroquine by parasites is not a result of an 
alteration of the original target but is rather a reduced ability to reach this target as observed 
by drug accumulation in the parasitic digestive vacuole which is lower in chloroquine resistant 
(CQR) parasites than in chloroquine sensitive (COS) ones.52, 53 Because chloroquine is a weak 
base which accumulates in the digestive vacuole via pH trapping, it was initially proposed that 
increases in the vacuolar pH would result in decreased accumulation.54 Subsequent studies 
have shown this not to be the case as measurements of vacuolar pH in chloroquine sensitive 
and resistant strains have been found to be similar.23 One of the more favoured explanations 
for this lack of accumulation has been proposed to be caused by a mutated membrane 
transport protein (PfCRT, Plasmodium falciparum chloroquine resistant transporter) which 
causes an increase in chloroquine efflux from the digestive vacuole resulting in decreased 
intravacuolar concentrations that are unable to inhibit haemozoin formation.55, 56 Wild-type 
PfCRT is found in the membrane of the digestive vacuole and is a member Of the so called drug 
metabolite transporter family of proteins. However, its normal function is unknown.55 The 
proposed mechanism of chloroquine efflux is through transport of chloroquine out of the 
digestive vacuole, which is further supported by the fact that chloroquine resistance is 
reversible by verapamil, a known membrane transport inhibitor.57 Only very recently did Martin 
et al.58 directly show transport of chloroquine across a membrane by mutant PfCRT, using a. 












It has been found that the key mutation in PfCRT for chloroquine re5istance is that of Iy.,ine (K) 
76 to threonin ~ (T). This mutation by itwlf i, not enough to convey resi.'tanc~ and .m v, rious 
other mutations (differing from strain to strain) seemingly are also required, probably to 
m'intain ,ctivity of the prote in " The K76T mutation re.,ults in the PfCRT tr,nsporter Iming a 
positive charge wh ich is believed to allow for the transport of chloroquine in its protonated 
st ,te, where previou,ly thi5 would not \-,"ve been p05sible bec~u,~ of c,tion-c,tion repulsion 








Pa, .. i~c cytosol 
pH ~ 7.3 
Figure 1.8. Chloroquine is monoprolon,t,," (CQH') un""r pa r.s ili, 'ylo,ol condilion, ,nd become, doubly 
p.-olon'led ICQ2H' ) when cro"inp, the pH p, r.d ien l inlo the dip,e' li,e v.cuole. In chloroq uine ,emitive par a~te" 
chloroqu ine a«u mu late, " the " lion-colion repu I, ion , between CQ2H' .nd th e pO'i!ively ch . rp,ed Iy~ne I K) in 
po~tion 76 on the Chloroquine Re,i<t.nt Tr.n'port (CRT) protein pre,ent> elflu • . Chloroqu ine co ncetltration, 
allow for inhibition 01 th e Fe{ III)PP IX delo.ific.tion proce". In chloroq uine re,imnt parasites, mutation 01 the 
po'it ive I¥,ine in CRT to ne<'trallhreonine IT). . llow< tor the t ron,po rt at ion of chiowquine out of the d i ~e,live 











CHAPTER 1. INTRODUCTION 
1.7.2 Mechanism of aryl-amino alcohol antimalarial resistance. 
The mechanism by which parasites exhibit resistance to aryl-amino alcohol antimalarial drugs is 
not well understood. It is believed that the membrane transport protein PGH-l (P-glycoprotein 
homologue), coded by the gene Pfmdr1 (Plasmodium falciparum multidrug resistance), is 
involved. Studies have shown that some laboratory mefloquine resistant parasites (e.g. W2-
MEF) have an increased copy number of Pfmdr1 and/or an over-expression of PGH-l which has 
also been shown to cause a decreased sensitivity to halofantrine and quinine antimalarials.61,62 
This amplification of the PGH-l protein has thus been suggested as a cause of r.esistance. 
Further evidence to support this has been found where increased chloroquine resistance in W2-
MEF resulted in de-amplification of PGH-l and subsequent increased sensitivity to quinine, 
mefloquine and halofantrine.63 There is evidence that contradicts this proposed resistance 
mechanism with some field studies reporting strains with no amplifICation of PGH-l that are 
mefloquine resistant, which suggests additional mechanislTl5 that may mediate resistance.64,6s 
There have also been reports that some mutations in Pfmdr1 may cause resistance to quinine 
and that there is some interaction of quinine and quinidine with PfCRT.66, 67 
While there are many theories as to the mechanisms of resistance to chloroquine and related 
compounds, it is clear that there is still much that is not well understood. To add to this is the 
fact that there is a lack of chemical diversity between many antimalarials and cross-resistance 
has begun to develop.68 There is thus a great need for the development of novel antimalarial 
drugs of differing structural classes. However, in order to be able to propose compounds of a 
new class as potential antimalarial drugs, understanding the mechanism of action of known 











CflAPrfR 1. INTRODUCTION 
1.8 Mechanisms of h~emozoin inhibition 
The mechanism of action of haemowin inhibiting antimalarial drugs is, unfortunately, not well 
understood. Literature has suggested two main pO." ible mode, of action. The first is a 
mechanism proposed for haemozoin inhibition by Buller et 01.,9 and involves the interaction of 
an inhibiting compound with the fastest growing faces of the haemozoin cry,tal (ClOI and 00·1). 
These faces are orientated in such a way that corrugated grooves are formed from which the 
propionic acid and aromatic surface of the Fe(I II)PPIX units are exposed (see figure 1.9a). It is 
with these protruding mOieties that haemowin inhibiting antimalarial drugs are thought to 
interact. As an example, chloroquine (CO) is shown modelled in the groove of the haemowin 
crystal and four possible intermolecular interactions were identified as a (i) porphyrin-COO 
CQ-R3NH+ salt bridge; (ii) porphyrin-CH., CQ·CI contact; (iii) porphyrin-C=CH 
contact and (iv) porphyrin-C=C (IHloud)· CQ-R,NH contact (illustrated in figure 1.9b).'9 This 
model is not Without critiCl.'m because CQ was modelled in its singly protonated state. Under 
the "cidic diEestive vacuole conditions where CQ i$ thour,ht to accumulate and interact with the 
haemowin, the doubly protonated form is the major species. However, w ith the discovery of 
lipid involvement in haemozoin formation, the monoprotonated species may we ll be present in 
a lipid environment "nd thus this is a plausible mechanism. 
b 
f igur. 1.9. i~) Model 01 p·ha"",alin, Yicw,-d " long the a axis, ,howinp, corrup,ated p,rooye, wh",e h,em{Jloin 
inhibiting .... tim.11., ial drur,< are thau ijh! to ;,d,orb. (b) C~loroQuine i; thoup,ht 10 as>ociale in the ~·haematin 
graoy~through lour interaction, Length, 01 inter.xtion, "re (i) 2 711, (ii) 3.0 11, li ii ) 2.411.nd (iv) 2.7 A. fi gure, 











OIAPTfR 1 . INTRODUcnON 
The se~ond proposed mechanism of action involves the associati on of quinol ine haemozoin 
inhibiting ant imalarials through electronic interdctions {such as n-stacking) with free 
Fe{II I)PPIX,'o,,, In th e ca5e of ary lm ethanol antim~ l~ria ls such ~s quinine and quinidine, it has 
been proposed that in addit ion to ]"[-st~cking. coordination to the iron ~e n t re of Fe{III)PPIX. 
through t he ~Ikoxide. occurs,"-lO However, owing to t he in ~~tiv ity of the epimers of quin ine 
and quinidine, addit ional int er~ctions other than coordination and n-stdding were obviously 
present- " Up until recently, these proposed interactions were only supported by UV-vis and 
NMR spectrometr i ~ evidence, More convincing evidence in support of thi s t heory was obt~ined 
wh en t he first crysta I st ructu re of d n ant i ma la rial d rug-Fe (III )P PIX com p lex, that of halofantrine, 
wa5 elucidated {see figure 1.10).'" The crystal st ructure showed halofantrine coordinated t o the 
iron centre of Fe{I II)P PIX through its benzyl alcohol moiety dnd favourable distances were 
observ ed fo r Il-stdck ing i nter~ction5 between the phenanthrene dnd porphyrin ring systems. In 
addition, ~n intermolecular hydrogen bond between th e tertiary amine of halofantrine and the 




y " OH "J A c, y 
ce, 
Fir ure LIO.la) Crystal structu re al the h'rm halot.ntr i n~ complex. F;gure reproduced Irom ref",e nce 76. ibi 
5tr"ct"r~ 01 halol,mrine, fl igh li ~ ht"'" , rN' ,""i catp key intr-raction, with Fe( IIliP PIX as be i n~ (Qordin"tion Ired i, 
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CHAPTER 1. INTRODUcr/ON 
The hypothesis that this additional interaction is an intramolecular hydrogen bond between the 
haem propionate and the quinuclidine nitrogen of the drug was proposed by de Villiers et al.76 
and is supported by computational results reported by the same authors. The findings showed 
that in order for the EQN and EQD complexes to form such an intramolecular hydrogen bond, 
they have to adopt unfavourable high energy conformations, while the QN and QD complexes 
can easily form the hydrogen bond, owing to the lower energy of the conformations needed. A 
plot of the ICso of each drug versus the difference in energies between the strained 
conformation needed for intramolecular hydrogen bonding and minimum energy 
conformations of each of the haem-drug complexes (6£), shows a linear relationship (see figure 
1.12). This linear relationship suggests that the ability to form the intramolecular hydrogen 
bond determines the antimalarial activities of each compound. 
4.0 








2.5 5.0 7.5 10.0 12.5 
t:E. I keal mor 1 
Figure 1.12. Graph of the ICso of quinine (QN) and its epimers versus the difference in 'energieS (L\E) between 
strained and minimum energy conformations of the haem-drug complex. figure reprod~d from reference 76. 
Thus the proposed mechanism of action for halofantrine and related antimalarials in the 
inhibition of haemozoin formation involves firstly anchoring the molecule to haematin through 
coordination to the iron centre and n-stacking with the protoporphyrin ring system. This then' 
allows for hydrogen bonding interactions with the propionate side chain to occur resulting in 











CHAPTER 1. INTRODUCTION 
In light of this new information, the rational design of novel antimalarial drugs can for the first 
time be proposed based on a similar mode of interaction with Fe(III)PPIX. Uncovering 
compounds with novel scaffolds that possess the potential to have strong interactions with 
Fe(III)PPIX is possible through the use of fragment based drug design as well as by gaining 
better understanding of the relationships of coordination, n-stacking and hydrogen bonding 
with Fe(III)PPIX. 
1.9 Fragment approach to drug discovery 
In the quest to identify novel hit compounds, fragment based drug design (FBDD) has become a 
popular alternative to techniques such as high throughput screening (HTS). This move towards 
FBDD is a result of the increased effICiency of this technique.77 While the use of HTS has 
produced many important hit compounds, the technique generally suffers from a low hit rate, 
meaning a large body of compounds (typically in the millions) need be searched in order to 
identify a small quantity of compounds of interest.78• 79 The FBDD approach is able to alleviate 
this HTS problem somewhat by screening lower molecular weight compounds (typically 150 to 
200 g/mol), termed fragments, as by decreasing molecular weight of compounds results in an 
exponential decrease in the number of different molecules possible with the same molecular 
weight.80 This results in smaller compound libraries needing to be screened, with the libraries 
themselves often containing compounds that can be either commercially available or require 
minimal synthetic modification. As a consequence, reported hit rates from FBDD approaches 
are typically higher than those obtained through HTS.78 An added benefit to the use of FBDD is 
that it provides for a more rational approach to drug discovery and can lend itself to a better 











CHAPT£ R l . !N11l0DunION 
f-8ll0 uses smJl1 molecules t o probe the bin d,ne Jflinity to a target. but bc(au ~e 01 the srncll l 
molecu lM sile 01 the fra gment, it is unlikely th~t the molecule will con tai n ~II the moiet ies 
req uired to produce stron!: target binding ~nd ~o i ndividu~ 1 bi nd in ~ affoni ty i ~ generall y low (see 
f igure l.13a to d. '" One approJch of FBOO is to identify fraements that bind to d,tterent sites 
on a tJreet ~Ild combine them into cl single compo und u~ i np, link er~ to give a compound th at 
has enhanced bi nd ing ~ ff i nitv (,ee ligure l.13dl ." In l act, th is approach can l e~ d to the 
development of stronger binding compounds than lho~e identified by HTS, as in many cases the 
HTS ident if ied molecule contains moiet ies which may not prov ide optImal inter~ct io n s with the 
target ,it e (,ee f igure 1.13e).70 
b , 
d , 
Figure I.B. <;m. 1I compound,. ,dent,l i&:1 t hrou~h the u,e of Irdgment b.""d drup, cIe'ign. exhib,t weak t.rp,H 
binding i. to cl . Combining i<>dividual f,.p,ments into a ~ ngle molecule id ) <an result in a M compou<"id wi th 
'troog larfet bind ing which may pro>ide even >tronp,er interoct ions than compou nds identif .. d throu~h hi ~h 











CHAPTER 1. INTRODUCTION 
FBDD relies on a variety of computational, biochemical and biophysical experimental 
techniques to obtain information about strength and structure of binding fragments.77, 80 
Computational methods are a useful tool in FBDD, where interactions of fragments can be 
modelled to identify potential hit fragments, while biochemical assays can provide information 
on binding strength. Biophysical techniques ~uch as x-ray crystallography and NMR 
spectrometry are routinely employed to provide physical evidence of the structure of fragment 
binding. Unfortunately, very few of these techniques can be directly employed to identify 
fragment compounds in the case of Fe(III)PPIX. 
At present there are several p-haematin (synthetic haemozoin) inhibition assays (see references 
81 to 83 for examples), including a HTS assay developed by Ncokazi and Egan.44 Using a 
fragment approach with these assays would be futile as almost all fragrm!nts would have less 
than the three required features (iron coordinator, aromatic n-stacker and hydrogen bond 
donor) of aryl methanols for p-haematin inhibition and thus the assay would likely simply give 
negative results. NMR techniques cannot be used bec use of the paramagnetic nature of iron 
which causes line broadening and x-ray crystallography is seemingly very difficult for this target 
as seen by the fact that there is only one reported drug-haematin crystal structure. While a 
computational approach can theoretically be employed for fe(III)PPIX, the nature of this 
compound does not make for definitive results and so is not very effective. To elaborate, 
because of the planar structure of Fe(III)PPIX there are few steric and electronic interactions 
that can constrain a compound into specific conformations, thus interaction between 
fragments and Fe(III)PPIX results in very flexible structures and can lead to multiple possible 
conformations. 
The most useful technique that can be employed for FBDD with Fe(lll)PPIX is that of 
spectrophotometric titration. This method is able to provide binding affinities (in the form of' 











CHAPTf~ 1. IlVrROQucr,,:W 
The UV-visible spectrum of free Fe(III)PPIX in it> monomeric form is generally subject to 
hypochromism in its Soret peak (see figure 1_14) when compounds, such as chloroquine, are 
tit rated into the solution, This effect has b~en attributed to the interaction b~tween the 
transition dipule moments of Ihe ,,-7,,0 eleClronic transition of Fe (III)PPIX and the ,,-e lectron 
cloud ofthe quinoline which Me in close proximity, ~' 
",------c--------, 
\" 
" " . , , , , , 
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figur~ 1.14. UV lII'ib le spectrum of f r.e monomer ic Fe(llIlPPIX (black linel .howirlp' hypochromism 01 th~ S-orH 
pe.' LJpon .Mil ion of q LJ ino l'"e, r e,ulti~g i ~ l~ presence 01 qui~o li "e: Fe(III)PP IX complex~s (r ed Ii nel 
Utilisint; spectrophotomNric titration_' and smoll compounds po,ses,ing int er~ct io n specific 
group, (for coordination, etc.), greater insiehts into the re lat ionships 01 interJ(t ions with 
Fe(III)PPIX can b~ obtained, and it may be possibl e to combine Ihese fr~gm e nt, to form new 
~- h"ematin inhibitors as potential st~rlin g points to novel antimalarials, 
1.10 Interactions with fe(III)PPIX 
The three key interactions of coordination, ,,-stacking and hydrogen bonding form the bJsis of 
the proposed mech~nism of action of halofantrine and related antimalarial compounds, While 
there exists an extensive body of literature on hydrot;en bonding interactions wi th carboxylic 
acid receptors, there are no reported systematic investigations into re lationships of 
coordination and ,,-sla(king interactions with Fe(III)PPIX_ Some insieht can be gained from 











CHAPTER 1. INTRODUCTION 
1.10.1 Coordination interactions. 
Investigation of the coordinating ability of various nitrogen donor ligands (imidazoles, pyridines 
and amines) with the haem octapeptide microperoxidase-8 (MP-8) by Pratt and co-workers85-88 
and N-acetyl microperoxidase-8 (N-AcMP-8) by Marques et 01.89 have previously been reported. 
These metaltoporphyrins, see figure 1.lSa, have been known to serve as model systems for 
haem proteins but also provide a monomeric derivative of Fe(III)PPIX in aqueous solution and 
thus are able to provide some insight into the coordination interactions with free Fe(III)PPIX. 
Both Marques and Pratt reported that under aqueous conditions, coordination to the iron 
centre of the metalloporphyrins was dependant on the pKa and hence basicity of the donor 
ligand. 
In these studies, four distinct families of compounds were identified. Imidazoles produced the 
strongest association constants, amines were found to be separated into two groups (I and II), 
with class I amines having the weakest associations, while class II amines shared a similar 
binding strengths to pyridines (see figure 1.lSb). 
Tr------------------------------, a b 
• 
. ~----------------~--~--~---' • , .t 
Figure 1.lS. (a) Molecular structure of microperoxidase-8 (MP-8) and N-acetyl-microperoxidase-8 (N-Ac-MP-8) 
when R = NH3+ and NHCOCH3, respectively. (b) Linear free energy relationships between associating ability and 











CHAPTfR 1. INTRODUCTION 
Marques et 01."" <3ttributed the formation of these separate families to the increase in electron 
density on the metal ,entre provided by the wordinated imidawle moiety of histidine. The 
imidazo le coordinates through its a-orbital and back bonding occurs between the metal 
d-orbitals and the empty IT'-orbitals of the nitro~en Ii~and. Strong a-donors, su,h as imidazole, 
,ause a polarisation of the t,. metal orbitals which results in an unsymmetri, distribution of 
electron density that <3ccumulates trollS to the wordinated li~and, These ele,tron rich orbitals 
provide stron~e r backbonding interactions, and thus gre<3ter associ<3tion interact ions, with a 
second incoming ligand should it have access to empty fl'-orbitals (see figure 1,16),"" 





fiiure 1.16. Sth.,mlit >hol".'irlg th e unsymmetrit o"umul,li(}ll of eleClr(}ll (\en'itv in th e t" orbita l, upon 
wordi nnion by the 'lrorlg a·dorl or im,do'oi •. The ~re"ter elenr(}ll d"" , ity tram to 'm iclazol~ re ,ults in monBer 
,"ord""tion 01 a second inwmirlf, lip"nd, prolli(\ed it "0 ",-,cteptor, ., ,tr""ger b,d;bonding inter.cti(}ll' ore 
pos;ib ;", Fif,U re adapted from reference 90 
As the sp' ni t rogen containing imidalOle and PYridine ligands have access to these orbitals, they 
form stronger association wnstants. However, sp' <3mine liJl:ands do not have IT'-orbitals and 
thus are not able to partake in backbonding interact ions with the metal, which acwunts for the 
separation of class I amines from imidazole and pyridine families. While class II amines are also 
not able to partake in n-backbondin~, the Jl:reater strength of association with N-Ac-MP-8 was 
attributed to the ability of these wmpounds to hydrogen bond with the propionate side (hains 
when bound Further separation between the imidalOle and pyridine families is attributed to 










C""PTfR 1. INTRODUCTIDN 
1.10.2 II-Stocking interactions. 
Whi le mJny models have be~n previOU51y prop05ed to describe IT-5tacking interactions, the 
most wid ely ~ccept e d description is th.Jt reported by Hunter ~nd S~nder5!' This model 
describes the IT-,tackinr, inter~ct i on ~5 the sum of v~riOliS ~ttr~ctive ~nd repu lsive non - cov~lcnt 
forc es between two aromat ic compound .1 (>umm~ris~d in f igure 1.17). The I ~rgest attractive 
contriblltion to IT-stack ing is de5cribed by van der W~~I, (VDW) interJction.1 which include 
dipole-dipole (e lect rostatic) inte r~clion5 (figure 1.17a): dipole-indllced dipole interaction" 
(figure 1.17bl ~nd induced dipole- induced dipole (London) interaction, (figure 117c). In theory, 
~ttractive charge transfer effects al"o h~ve the potential 10 influence interJctions but the 
energetic5 of the5e forces are generally regarded as negligib le. Solvophobic effect5 (figure 
1.17d) in th~ form of d~solv.Jtion and po l ~ri5ing effect of ~romat i c interact ions are also 
important, with po l ~r ~olvent s provid ing more favourable rl-.lt.Jding intN~ction5. The large5t 
unf~vour~b l e contribution to rHtack ing is P~uli repulsion (figure 1.17e) which becomes 
significant wh~rl ~I~ctron clouds begin 10 over lap. It is thi s term whICh hJs.J '> igniticJrlt effect on 
the geometry of II-, faded molecul~s."· 9' 
- Perm.nent dip,"e - Induced dip,"e 
X Sub'tituent or 
hetero.tom 




Figure 1.17. N nn-cov;, I~nt forc~, re,ponSib le for . rom"Le ~-.,t""k i n ~ i nt~r"[t,"n'. I~I dipol~ di po le interi1ction,: 
Ib) dip,"e-ind",,€'d dipol~ int~r.ction'; 1<1 induced dipole- induced dipn l ~ in ter ;,eti ()llS; Id) ",l\Iophobic effect;; 











CHAPTfR 1. INTRODUCTION 
Through experimental method, it wa, found that l"[-stJcked JromJtic molecules /JVOlir either 
on edge· to-face (T-,haped) Or offset staded geometry."' Molewl~r modelling by Hunter ~nd 
Sander,", u ~in g their description of I"[·,tacking. coliid account for the experimentally 
determined Il-stilcking orientations when th e aromatic rin~ system Wa5 based On a charge 
distribution model (see fi gll re 1.18). Th is model treats the electrooegati ve natllre of the Il-
electron cloud J, being slightly necat ive but 5ince the rinc 5Y5tem is neutrill, the" frilmework is 
thus considered "s slightly p05itive. giving rise to a quadrupole. It is the 1"[-0 attraction that 
form, the bJ>is of the Il-stacking interaction, althollgh geometry is largely governed by the 
"bility to overcome Il-I"[ repul5ion5 (Pauli repuI5ion). The T-5haped (figure 1.l8a) and off5et 
stilcked (figllre 1.18b) geometrie~ are favollred over other geometries, ,uch a, face-to-face 
(figure 1,18c), owing to the minimaill-I"[ repul5ion effecb experienced" 
,. 
b 
- Attroctl vc IT cr in',-",o rtlO n, 
X Re pul,,;ve non inte r,eli()", , 
Fil ure 1,18. Geo met rie, oil"[-'lK. in~ "rDmati( r i n~ ' y,tem' ,j') Ed~e-to · f.( e {T-,hapedl and (b) olbel , I".ed 












CHAPTeR 1. INTRODUCTION 
Because of the sienif,cant effect of rep ulsive n-n interactions on the st re ngth and geomet ry of 
lI- st ~ck i ng interactions, Hunte r and Sanders91 theorised that ~inc e inco rpora tion 01 ~ u b~t ituents 
or hete roato ms onto the n-stacki ng ring systems affect electron densities of the IT-cloud I~nd 
thus I1-IT re pulsion), they would affect IT-stilcking interactio ll'>. For no n·polilrised systems (no 
heteroatom present ), sub,t ituents which ~re electro n oo nJ ti ng wo uld destabilise l1-stacking 
interactions by incre~ si ng electro n de ns ity in Ihe rl-electron cloud il nd c;au~inE Ere"ter IT-IT 
re~ul'>ioll'> (see figur~ 1. 19a). Converse ly, substit ue nts that Me electron withdrawing would 
decrease n-IT repul sive effects, thus favouring ll·stacking interactions (s~e lieure 1.19b). 
Incorporiltion 01 h et~roatom ' into th e ri ng system CJuses po lar isation of t he molecule ~nd 
results in addit ional ~tom-atom and alom-"o e lectros tat ic ~ffects, In th~ c a~e of hl Ehl y 
pola ri s~d molecule'>, it w~s c al,u l~t e d th~t atom-<ltom interactions Me dominant and while 
at om -ITO interactions al'>o have s.ome significance, " -0 interaction:, be~ome 01 l~a'l impo rt ~n,e. 
The ove ra ll effect 01 the presence of a heteroatom in a ring system w~s t heori sed to provide 
bette r n-st~ding interact ions ilS hetNoatotn,> reduce electron den ~ity in the fi nE."' 
, 
x Rep ulsive n: -n: inH'"etions 
,,-_x 
b 
Figur. 1.19. E/fect' PrDpo.e-d by Hunter .nd S. nd",," on ~-'Iacking inler.cl iom by 'lnl roduci~~ .ro"lilti, 
, ub,tituent" (al Introouetion 01 ~""tron donating grou p' iocrea,e ~- oI"ctrM demity .~d ~-n replJ l, io n, Ih u, 
would disrupt n·,to,king in teraction •. (bl Introduct ion 01 ~ ettron wiUldr.wlng p,roup' decre"e ~ ettron den<ity 











CHAPTER 1. INTRODUCTION 
Since the description of the n-stacking interaction by Hunter and Sanders91, there have been 
few reported investigations which quantitatively describe such interactions. Fortunately, work 
by Schneider et 01.94,95 has provided one of the few detailed investigations of quantitative n-
stacking interactions with porphyrin ring systems under aqueous conditions and is of particular 
interest owing to the structural similarities between Fe(III)PPIX and the water soluble 
porphyrins used. The investigation of n-stacking interactions involved the measurement of 
association constants of various aromatic ring systems (0 to 14 Jt-electrons in size) with 
porphyrins. The reported findings showed a remarkably simple linear free energy dependence 
of associating ability (~G) on ring size in the form of number of n-electrons, where an increase 
in ring size resulted in an increase in strength of association with the porphyrin (see figure 
1.20a). In addition, it was found that a decrease in solvent polarity (accomplished by increasing 
methanol content in water) had a detrimental effect on n-stacking interactions between 
phenanthrene and a water soluble porphyrin (see figure 1.20b). This confirms the solvent 
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Figure 1.20. (a) Linear free energy relationship reported by Schneider and wang94 which indicates a stronger 
n-stacking ability with an increase in the number of aromatic n-electrons. (b) n-Stacking association between 
phenanthrene and a water soluble porphyrin decreases as solvent polarity is decreased. Figures reproduced 











CHAPTER 1. INTRODUCTION 
Investigation on the effect of substituents on n-stacking interactions is somewhat less clear cut, 
with authors such as Kim et al.96 providing evidence suggesting such effects are negligible, while 
studies by Liu and Schneider95 revealed the opposite. Findings by Liu and Schneider suggested 
substituents, other than alkyl groups, do affect the strength of n-stacking association but they 
were never able to correlate these effects with a physical property such as Hammett constants 
(values describing electron withdrawing ability). Interestingly, heteroatom effoos were also 
found to be negligible.95 from the results of these and many other authors it is obvious that the 
effects of aromatic ring substituents have a more complicated role than that proposed by 
Hunter and Sanders.91 
1.10.3 Hydrogen bonding. 
Hydrogen bonding remains one of the most important intermolecular interactions and affects a 
diverse range of areas from molecular recognition and aggregation to various inorganic and 
biological systems. The hydrogen bond is defined as a local bond of the form X - H··· A, where 
X - H acts as a proton donor to A, is electrostatic in nature and has pronounced 
directionality.97,98 Because of the wide-reaching importance of this fundamental interaction, 
large bodies of work have been devoted to the investigation and understanding of the 
hydrogen bond. 
With the proposal of a hydrogen bond interaction with the propionate side chain of Fe{III)PPIX, 
the hydrogen bonding interactions of carboxylic acid groups with various proton donor moieties 
is of particular interest and a review by Fitzmaurice et al.99 titled 'Synthetic receptors for 
carboxylic acids and carboxylates' provided useful insights into the selection of potential 
hydrogen bonding moieties. The review specifically highlighted the use of nitrogen containing 
(i) ammonium, (ii) guanidinium, {iii) urea, (iv) thiourea, (v) amidopyridine and (vi) amide 
moieties as receptors for carboxylate anions. While all the above mentioned moieties are able 
to form at least one hydrogen bond with a carboxylate anion or carboxylic acid, classes (i) and 
(ii) have an additional electrostatic interaction which provides for stronger interactions with 
carboxylates. This interaction is known as a salt bridge and is the attractive force experienced 
between the delocalised positive charge, produced by the protonated state of the nitrogen, and 











CHAPTER 1. INTRODUCTION 
Ammonium salts (i) provide the simplest hydrogen bonding interaction between a protonated 
amine and carboxylate anion. Individually, these interactions are not particularly strong and so 
are generally utilised as polyamines (such as investigated by Kimura et al.1OO, see figure 1.21a) 
or are used in conjunction with other stronger hydrogen bonding moieties to give added 
stabilisation. Single hydrogen bonding moieties have also been investigated, with Barboiu et 
al.101 reporting the carboxy1ate binding of various amino acids through the use of a single 
ammonium moiety (see figure 1.21b). 
a b 
Figure 1.21. Examples of multiple (a) and (b) single ammonium hydrogen bonding groups used to bind 
carboxylate anions.100, 101 Figures reproduced from reference 99. 
Guanidinium salts (ii) have the ability to form strong bidentate hydrogen bonded interactions 
with carboxylate anions (see figure 1.22a) and with their high inherent pKa values (ca. 13.599) 
the majority of species present in solution is in the protonated form meaning a greater 
percentage can partake in salt bridge interactions. It is these two characteristics that account 
for the strong hydrogen bonding interactions observed between guanidines and carboxylates. 
The binding ability of these moieties with carboxylates has been extensively investigated and is 
exemplified by the work of Schmuck102 where strong binding of N-Ac-a-amino acid carboxylates 
using guanidine moieties in combination with pyrrole and amide groups were observed {see 
figure 1.22b). An interesting subclass of guanidinium salts mentioned byfitzmaurice et al.99 is 
that of amidinium salts. These moieties provide a similar hydrogen bonding motif as 
guanidinium salts, but are less basic in nature. Diamidine compounds (see figure 1.22c) 
reported by Mayence et al. 103 have shown good antimalarial activity and were found to inhibit 
l3-haematin formation. Whether this activity is caused by the amidinium moieties hydrogen 
bonding to the propionate side chain of Fe(III)PPIX or not is uncertain. Neverthe1ess the 















Figure 1.22. (a) Hydrogen bonding motif between guanidinium and carboxylate moieties. (b) Example by 
Schmuck102 in the use of guanidines as receptors for carboxylate binding. Pyrrole and amide moieties are used 
to supplement the hydrogen bonding interaction.99 Figures reproduced from reference 99. (c) Diamidine 
compounds reported by Mayence et al. 103 have shown the ability to inhibit ~-haematin formation. Figure 
reproduced from reference 103. 
The remaining moieties (iii to vi) described by Fitzmaurice et al.99 are less interesting owing to 
their inability to form salt bridge interactions and thus they provide weaker overall interactions. 
Moieties (iii) and (iv) are known to have moderate hydrogen bonding strengths with 
carboxylate anions, but these still do not provide strengths comparable to guanidinium 
moieties without modifying the electron withdrawing ability of neighbouring groups. Because 
of the low pKa values for moieties (v) and (vi), these groups are generally utilised as hydrogen 
bond donors for carboxylic acids, particularly in non-polar environments. 
Owing to the nature of Fe(III)PPIX at digestive vacuole pH where one of the propionic acids is 
almost always deprotonated/04 there exists the potential for salt bridge interactions in addition 
to hydrogen bonding interactions and thus ammonium and .guanidinium moieties were of 











CHAPTER 1. INTRODUCTION 
1.11 Alms and objectives 
1.11.1 Aims. 
The overall aim of this project was to produce compounds using a rational fragment design 
approach in an attempt to inhibit ~-haematin formation and thus confirm the hypothesised 
mechanism of action. This was envisaged to be achieved through two steps by: 
1. Investigating the relationships of coordination and rt-stacking interactions with 
Fe(III)PPIX. 
2. Exploiting these relationships such as to propose and synthesise novel compounds 
which would have a strong possibility of inhibiting ~-haematin formation. 
1.11.2 Objectives. 
The specific objectives required to attain the proposed ims were to: 
1. Spectrophotometrically obtain association constants for various coordinating ligands 
with Fe(III)PPIX and relate them to a physical property of the ligands such as pKa• 
2. Spectrophotometrically obtain association constants for various aromatic ring systems 
with Fe(III)PPIX and PPIX and relate them to a physical property such as number of 
rt-electrons. 
3. Identify small molecules that maximise coordination and Tt-stacking interactions to be 
used as scaffold compounds. 
4. Incorporate a hydrogen bonding moiety onto the scaffold and use molecular modelling 
techniques to propose compounds with the potential to inhibit ~-haematin formation. 
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CHAPTER 2. INVESTIGATION OF COORDINATION AND n-STACKING INTERACTIONS WITH FE{III}PPIX 
2.1 Introduction 
To date, no detailed investigations of factors governing coordination and n-stacking 
interactions with Fe(III)PPIX have been reported and thus interactions of this nature are not 
well understood. By attempting to uncover the underlying relationships of these interactions, 
the information obtained would be extremely useful in the design of template compounds 
which could anchor the molecule to Fe(III)PPIX and provide a scaffold to which hydrogen 
bonding groups may be incorporated, hence conforming to the proposed model required for 
inhibition of ~-haematin formation. 
2.2 Coordination interactions 
Owing to the complex nature of Fe(III)PPIX speciation/
104 experimental conditions in the present 
study were limited to a 40% (v/v) aqueous DMSO solvent system at pH 7.4 in order to obtain a 
monomeric Fe(III)PPIX species.75 This pH constraint me nt that protonation competition had to 
be explicitly taken into account for donor ligands that have a pKa higher than 7.4. Equation 1 
was employed to calculate the pH independent association constant for coordination with 
Fe(III)PPIX (log Kc) from the observed association constant at pH 7.4 (log Kc,obs). 
log Kc = log Kc,obs + Log[l + 10(PKa-PH)] (1) 
Utilising this technique and correcting for protonation, association constants for a variety of 
pyridine, imidazole, amine and phenolate donor ligands with Fe(III)PPIX were determined. 
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Figu re 2.1 . Typic.1 ,pectroscopic chonr,es obt.ined upon . ddition to Feilll)PPIX (d il ution corrected) 01 lironds 
lorminr,. 1:1 (a) .nd 2:1 (b) complex, In'~". E,p. nsion 01 Q b.nd rerion, v.ith .rrow, indic.t inr, i'-Osbestic point, 
in (a) but not (b ). (,) Non-l in".r le05 t , qu.res fit (red line] 01 the d.t. Ibl.c~ ( ire le,). obt . in ed fro m (0), to 
eq ". ti on" 2 and 3 (.ee ch.pt", n respe ctive ly. (d) Non-l ine or le05t squ.r., l it (red line) 01 th e d.t. (bl oc1< ( ire le, L 
obnincd I ro m (b), to equa ti on" 2 ond 3(,ee ch apter 7) . r e,p~ct ively 
An alys ing the data obtained from the spectrophotometric t it rations. it wa5 found that t he 
majori ty of the compounds tested formed 1:1 li gand Fel lli)PP IX complexes. In these cases, 
changes in the absorbance spectra were found to be confined to the intensity of bands with no 
sh ifts occurr ing. The most prom'lnent change 'Id entified w"' hypochromism of the 50ret peak 











CHIIPTeR 2. IN~'5nG~ nON OF COORDINII DON ~ND rc-sr~(KING IN fERACflDNS WITII h(III}PPIX 
However. some pyrid ine ~nd imidowle li g~nds (compounds 6. 8, 10 "nd 13, see tJble 2.1) were 
found to form to a 2:1 complex which Te-;ulted in the form3tion of ~ low spin iron cent re which 
was spectroscopical ly ch~racteri,ed by both hypochromism and a sh ift of the Soret peJk to a 
longer wJvelength, illustrJted in figure 2.1b, 3, well as incre3sing intensity and sh ifts in the Q 
b~nd reg ion. Format ion of th e 1:1 complex of imidalO le with Fe{III}PP IX w~s found to be a 
stcpwise process with clCM evidcnce of deviJtion from the cooperative model which is most 
clearly observed ~t low and high concentr~tions (figllre 1.2). The observation of such a 
5·coord inJte intermediJte ,pecies i, uncommon with imid.JlOles. M 3ny authors report ~ 
coo pe r~ t iv e mech~nism with h~emin under v~"ous ~queous and non·Jqucous 
environments 'O'i·,m, however, these findin gs are in agreement with those of M3fques et alIiO 
where' simi lar stepwise process was discovered with imidalOle for haematohJemin. 
2 , 
'" " " 
...... "'~ 
, e \ : , 
8 \ ;. " . , , < , .ti , '" '" " 
• ~ . ~ , , ~ ___ J, 
k~:;=-:=" ~:" '-1 ~oo 0.25 050 0 75 00 1.25 1.50 
[imidazo le] I 10-2 M 
Figur~ 2 .2. Non- li ~edr le"t 'quare, fit, of experl ment,1 da lJ (black circle,) oblJi ned Irom spectrophotometric 
t il rat i o~ of imidJzo le . Dola were fitted to 2:1 ,tepwi,e I,olid red li ne) .nd cooperal ive (d.!,hed b lue linel 
mooel< "'inp, eq uations 3 .nd 4 I,"e chapt", 71. re'pe cli"e lv. Insets. Pronounced devia tion ~ 'l'I<lwn lor the 
cooperative. but n<ll stepwise m<lde l .t low .nd hip,h conce ntration; 01 imi dazo le. 
Plotting log K, of the coordinating ligand, aga inst their corresponding pK" value, summarised in 
table 2.1, resulted in a single linear free energy rel~t ionshi p {LFER}. shown in figu re L.3. The,e 
findings ,uggest that under condition, devoid of proton competition, such as in a lip id or 
organ ic environment, coordin~tion to the iron centre of Fe(II I)PPIX is based so lely on the 
basicity of the donor ligand. The lfER between pK, and coord ination strength with Fe(IIIjPPIX in 
40",1, aq ueous DMSO is described by equ~tion 5 
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figure 1.3. I inc" fre e ~rwriri rcl' tionship bctweel1 the pl l il1 dcpenMI11 ,,,,,,d.lion cons t,mt II "\; K.-I . l1 d pI(, of 
nil rog~11 ",d o'yg~11 donor li ~",(h. This r~I" ionship is de,eribcd by 10£ K, ' O.7116)xpK, l.0151 with r' · 0.93 
In order to confirm the hypothe,i, of coordination under pH independent condition>, 
association constants of those ligands, which are free bases, were then determined with 
Fe( III)PPIX in an organic so lvent system. The ,olvent ,y,tem consisting of 20% (v/v) DMSO in 
methanol was chosen, and from Beer-Lambert law studies, it was fou nd that monomeric 
Fe( llljPPIX species werc obtaincd at (On(cntrations of up to at least 1. 5 x 10" M (figure 2.4J). 
A>soc iJtion con5tants of nitrogen donor ligands were then determined in the organic solvent 
system (log K,_",o)' values ,ummarised in tJble 2.1, where ,imilar >pectroscopic changes JS 
described for the 40"h (v/v) aqueous DMSO solvent system were observed. Ob,Nved 
Js,ociation const" nts obta i ned in the ore" n ie solvent ,y,tem (log K,_ "oj were then compared to 
the corresponding ligand ba5icity and a LFER was obtained which is >imilar to th at in ~queous 
DMSO (see f ieure 2.4b). This rc,ult confirms thilt in the Jbsenee of proton competition, log Kc of 
ligands with Fe (llljPPIX is indeed directly proportional to the ba, i(ity of the donor lir,a nd and 
demonstrates that the LF ER ob,Nved in f ieure 2.3 is not an arteiJct of correction> made to 
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Figure 2.4. (3) Be el -L.mbert law plot of re{IIIJPP IX in" 20% (~!~i DMSO in me lhano l ,oNent sysi em, [ 'tincti"" 
(oeffO(ient was fou n ~ to be 102 4(H) M em' (bi linear f",e "'wr~y le l'lion,h ip between ."ociation ("",tont, 
obta in e~ in lOll (v/v) DMs.(l In mdh"nol ( I o~ K,." I ond pK, 01 N-donor lif,.nd< (see t"b le 2.1 for comroun~s)_ 
Th i' retJti""s.h lp i, de5{:ribed hV 1"Ij K,.", _ O_H(lixpK. - 3(11 with r' = 0.87_ 
T~ble 2.1. Observed and pH i ndepende nt a_,_<;oc iat ion com tant , as we ll "' pK, va lue, o( nitrog~n ~nd 
o.ygen donor ligand' used in the determination of coord inat ion a«oci"tion Con,tilnts with Fl'[III)PPIX 
" Compound ". log K, "" l<>g K, log K<~I , 1 naphth"nol 9_34 ' 2_12! 0,02 4,08 " , 2-phenylimid.wle 6_39 • 1A1! 0.01 2.45 2_78 ± 0_02 , 3,5-di<hlorophenol 8_19 ' 2.63! 0.03 3.53 " • 3-melhoxyphenol 9_65 ' 1,63! 0,02 3.94 " , 4-dimethyl.m inopyridine 9_87 ' 1.45! 0_01 .~ 4.83 i 0_05 
• 415)-methyiimid.wle 7_54 ' 2.18 ± 0.10 2.59 2.0110_03 
3,16! 0_10 3.57 2.4510_03 , 4-metho<vphel1ol 10 21' 1.39! 0_03 4. 27 '0 
• 4-methylpyridine 6_03 • 1.34 t O_OH 130 1,01!003 
1.25 t 0_00 1.27 W. , butyl.mine 10.64 • 1.03 t 0_01 4,94 4,84 = 0_07 
'" imidazole 6.99 • 2.17 = O_OS 2,34 2,59 = 0_01 3.5110.06 ,~ 2.56 = 0_03 
" marpoo li n<> 8.49 ' 2.591 0.08 3,78 4_14 = 0.06 " phenGI 9.9H ' 1.4210.0S 4.06 "' 
" pyridin~ 4.H1 ' 0,77~0,05 0_78 0.51 = 0_04 0.82! 0.02 0_82 WO 
, Re lerence 111 
., Reference 112 











CHAPTER 2. INVESTIGATION OF COORDINATION AND n-STACKING INTERACTIONS WITH FE(III)PPIX 
The observation of a LFER under aqueous conditions is similar to results obtained by Pratt and 
co-workers85-88 with MP-8 and Marques et al.89 with N-Ac-MP-8, except that those authors 
obtained four separate LFERs for amines, pyridines and imidazoles. As detailed in section 1.10.1 
the formation of the four separate families was attributed to the Jt-backbonding effect caused 
by the coordinated histidine ligand and hydrogen bonding ability of the ligands. It is likely that 
the absence of this histidine ligand in free Fe(III)PPIX, which is five coordinate, leads to the 
single linear relationship seen here, obtained since no analogous effect on Jt-backbonding is 
possible. 
This explanation is further justified by the association constants obtained in this study for 
imidazole and 4(S)-methylimidazole where the formation of the six coordinate species of 
Fe(III)PPIX was found to be more favourable than formation of the five coordinate species, as 
indicated by the significantly larger second association constant obtained with these ligands. By 
contrast, with pyridine, the second association constant is only a little larger than the first. 
Interestingly, this Jt-backbonding effect appears lessened in the organic solvent system as the 
second association constant obtained for imidazole derivatives (compounds 6 and 10) in 20% 
(v/v) DMSO in methanol is similar in magnitude to the first. This effect is also observed for the 
pyridine derivatives (compounds 8 and 13) where a second association constant could not be 
determined, presumably since it is much weaker than the first. A similar effect of decreased 
second association constant was observed by Marques et al. 110 with pyridine and imidazole in 
coordination investigations with haematohaemin in a methanol solvent system. 
As an aside, the association constant of l-acetylimidazole with MP-8 and N-AcMP-8 was found 
by both Pratt and Marques et al.85-89 to have a greater than expected value based on the 
compound's pKa• However, in our hands, it was found through proton NMR that in an aqueous 
environment the acetyl group undergoes rapid hydrolysis to give imidazole and acetic acid. This 
process accounts for the greater than expected association constant obtained for 











CHAPTER 2. INVf5T1GA TlON OF ((JORDINA TlON AND ,,·STACKING INTf~AcrION5 WITII FE(III)PPIX 
Wh ile the fi nding, obtained fo r coord inat ion to Fe(IIIjPPIX are similM to the results 01 Pratt et 
01."'"" and MMques et 01."'", the abil ity to quant ify t hese interact ions with Fe(III)PPIX is of 
significance a, by combining the equation, 1 and 5. equat ion 6 was derived which is able to 
predict the observed coordination constant (log K,. ,., ~) at any deSired pH, provided the pK. of 
the ligand donor atom is known. 
(' ( 
From eq uat ion 8, it po>sible to predict ob5erved a>sociation constants for compounds with a 
range of pK, values under the a~ i dic condit ions known t o occur in the digestive vacuo le 01 the 
malaria parasite. The mea,ured vacuo lar pH of 4.8 - 5.4 has been previously reported.'" l' 
Figure 2.5 shows the curve obtained when the predicted log KC• Cl k va lues (calcu lated from eq 6 
at pH 4.8) are plotted aga inst pK, . A compound with a pK, value of 5.15 is identified as the 
opt imum under these cond itions. At this opt imum a very low associat ion constant is expected, 
Ie» than 0.6 log unit>, ind icating that coord inat ion under these cond itions is wea k and wou ld 
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Figure 2.5. Curve of predicted coord in'tion " socidtion const , nts IIDr K" "",. obta inC'd using cquolion 101 vc"", 
pK. und.,.,. acidic (pH 4.8) 'Queous (OflditiOflS simi lar to the digestille Y,cuol e of Ihe malar i" P"""tp. Str~n~">t 











C"APTf~ 2. IIIVnnGA nOli OF COO~DIIIA nOlI AIID IT-Sf ACKIIIG IIITfHACTI01I5 WITH Ff(III)PPIX 
z.~ ll-Stacking in teractions 
Quantitative studies of 1l-,tJcking interJctions in aqueous solution with porphyrin> are few, 
with Schneider et OI.~4. 'i'~ providing one of the few detailed investigations. In the present study, 
spectrophotometric titrations were employed to determ ine the d.l,ocidtion constdnts ari,ing 
from n-.ltdcking interaction, between simpl e ~rom~tic compounds ~nd the porphyrin rin l( 
system . BecJuse of the hydrop hobic nature of many aromJtic compound.l, substituent.l such as 
carboxylic acid.l and ~lcoh ols Jre required to aid solubility under aqueous experimen ta l 
conditions. Unfortunately, becau,e of the,e moietie" n-stJcking investigations with Fe(II I)PPIX 
proved more challenging thdn the coordination invest igations becou,e of the possibility of 
coordination to the iron centre by the various solubilising aromatic sub,tituents. Thus in order 
to obtain assa<;iation constant, re,ultinl( only from /I· stacking interactions, iron free PPIX was 
u,ed as a model system for Fe( III)pP IX. Beer, law ,tudie, under the 'dme dqueous DMSO 
conditions as used in coordin~tion investigations indicated th~ t the monomeric PPIX species 
exists below concentrations of approximately 5" 10.6 M, with deviation from lineJrity Jt higher 
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CHAPTER 2 . INVESTIGATION OF COORDINA TID'"' AND n -STA CI(ING INTERACTIONS WITH FE(III}PPIX 
Association constants arising from n -st acking interaction s (log Ksl with PPIX were determined 
for a range of aromatic compound s (t ypica l spectra obtai ned shown in figure 2. 7) with ring si ze 
limited t o 14 or fewer n-el ectron s because of interference in the vi sual absorption region by th e 
larger rin g systems which <Ire chromophores. Fortunately, assoc iJtion constants with Fe(llIjPPIX 
for a few of the compounds (1, 14, 16, 20 and 21. see t able 2.2) cou ld be measured because 
steric hindrance prevents coordination from occurring. All compounds tested obeyed a 1;1 
associat ion model, summarised in table 2.2. and an average decrease in IT·stacking with 
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Figure 2.7. (a) Typi[al spectroscopiC ,hange~ (dilution correct ed) obtained With ligands forming a 1:1 complex 
With PPIX. (b) Non-linear leasl .quares fi t (red line; of the data obtained Trom la) {black Clrdes). fi tted to a 1:1 
association model using equation 2. 
Plotting log K, with PPIX against th e number of n-e lectrons of the co rrespondin g aromatic 
compounds produced a LF ER. shown in figure 2.8. Th is suggest s that an increase in the number 
of " -electrons in the ring system result s in an increase in n-stacking associat ion with PPIX. Data 
scalter above and below the be~t fit line are attrib uted to substituent effects of the aromatic 
r ing system s which cou ld have a posit ive or negative effect on " -stacking interactions. 
Un fortuM t ely, attempts at unravelling substituent effect s from th e sm all data set Obta ined 
fail ed and further experim entJtion is requi red to understand and quantify thei r effect on 
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Figure 2.8. lin ear free energy relationship between l't"stacking Jssociatlo n (log K,) and the corr ... ~pondin e 
number of a-elect rons (nn) of th e aromatic compound , This relation ship IS dp,scrlbed by log K, : 0.23(2 )xnn • 
05:;( l 8) with r':; 0.91, 
Table 2.2. Association constant s determined fo r n -s tacking i nterac t ions w ith PPIX and Fe(I1l)PPIX. 
log I( 
N, . Compound n-electrons PPIX Fe(III)PPIX 
1 I-n~phtha no l 10 2.86 = 0,03 2.12= 004 
5 4-dimet hylamino pyridine , 2,21 :: 0.02 CP 
10 imidiJIole , 1 91 : 004 CP 
12 phenol , 1.!)9 : 0.14 CP 
13 pyridine , J 66 1 0. 14 CP 
" 2,6-1ulidine 6 2. 17:!: 0.09 1.71 :1 007 15 9-aminofluorene 12 336 10.04 CP 
16 benzimidalDle 10 2,72± O.O4 2,30:1 0,02 
17 benlDic acid 6 1 90:t OlO CP 
18 benzy l alco hol 6 2,22 ± 0.08 CP 
19 benzyl aminE' 6 1.77 ! 0.03 CP 
20 quino line 10 2,GO ± 0.07 1.97 i 0.02 
21 5- methyl-I , 10-phenant hroline 14 3.76 t 0.05 3.15:t 0.05 
22 4-quinol ine methanol 10 322 ± 0,08 CP 











CHAPTER 2. INVESTIGATION OF COORDINATION AND n-STACKING INTERACTIONS WITH FE{III}PPIX 
The findings obtained for n-stacking interactions with Fe{III)PPIX and PPIX are in agreement 
with the trends obtained by Schneider et 01.94, 95 for other water soluble porphyrins. The 
observed decrease in n-stacking association with Fe{III)PPIX as compared to PPIX is not 
unexpected for a metalloporphyrin, since Schneider and Wang94 observed a similar effect with 
zinc porphyrins. This decrease was attributed to distortions in the porphyrin ring system as a 
result of the presence of a metal centre. However, there exists a possible additional explanation 
for this observed decrease that is based purely on the availability of association sites. PPIX has 
two possible faces with which aromatic n-stacking interactions can occur. Owing to the 
coordinated axial water ligand, a 5-coordinate species of Fe{III)PPIX is produced75 which thus 
has only one sterically unhindered face that allows interactions with n-stacking molecules. This 
statistical decrease in association sites would account for log 2 (O.30 log units) of the observed 
deficit. The remaining 0.27 log unit decrease can be attributed to the doming of the 
metalloporphyrin ring system. 
Once again, while this observed trend was not entirely unexpected based on literature 
precedent, the quantification of this interaction with PPIX is important. By incorporating the 
observed decrease in n-stacking strength with Fe(III)PPIX into the equation describing 
n-stacking with PPIX, equation 7 was derived which is able to predict the n-stacking association 
constants (log Ks) of simple aromatic compounds with Fe(III)PPIX, where nn is the number of 
n-electrons in the aromatic ring system. 
log Ks = 0.23(2) x nn - 0.0(2) (7) 
2.4 Coordination and Jt-stacking combined 
With LFER equations that describe coordination (eq. 6) and n-stacking (eq. 7) of compounds 
with fe(III)PPIX, it remained to be seen whether compounds that can both coordinate and 
n-stack simultaneously would simply exhibit an additive effect of log Kc and log Ks on the overall. 
log K. Association constants of compounds that could partake in both interactions with 
Fe(III)PPIX were determined and compared with the individual contributions of coordination 











CHAPTER 2. INVESTIGA TION OF COOROINATION ANa n-STACKING INTERACTIONS WITH FE(III)PPIX 
It was found that compounds containing a benzylic alcohol donor ligand have similar observed 
association constants to the combined association constants predicted by equations 6 and 7, 
and so by combining equations 6 and 7, a general equation, 8, was obtained which is able to 
predict the association constants of any such compound with Fe(III)PPIX. 
log Kca1c = a x {0.71(6) x pKa - log[l + 10IPKa -pH 1J - 2.6(S)} + ~ x {0.23(2) x nTl - 0,0(2)} (8) 
a = 1 or 0 and ~ = 1 or 0 
Where a = 1 if the ligand coord inates or 0 if it does not and ~ = 1 if the ligand n-stacks and 0 if 
does not. 
In order to ascertain the accuracy of equation 8, the observed association constants for all 
compounds tested with Fe(III)PPIX (log Kob,) were compared to the predicted association 
constants calculated from equation 8 (log Kco lc), The results obtained, tabulated in table 2.3 and 
shown in figure 2.9, indicate that accuracy of equation 8 is reasonably good given the 
limitations of this approach, producing an average e rror between predicted and actual 
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Figure 2.9. Comparison between ob<;erved association constants with Fe(III)PPIX obt~i n ed through experim\'nt 
(log Ko,,) and from prediction using equation 8 (log Kc.~ )' Averdge error between values is ± 0,27 log units, 











CHAPTER 2. INVESTIGATION OF COORDINATION ANO n-STACKING INTERACTIONS WITH FE(III)PPIX 


















17 benzoic acid 
18 benzyl alcohol 
19 benzyl amine 
20 quinoline 
21 S-methyl-1,10-phenanthroline 
22 4-quinoline methanol 
23 1-naphthlene methanol 
- Reference 111 
b Reference 112 
c Experimentally determined (see chapter 7) 
pK. log Kobs log !<calc 
9.34 - 2.12 t 0.02 2.24 
-6.39- 2.41 t 0.01 1.88 
8.19- 2.63 t 0.03 2.34 
9.6S- 1.63 t 0.02 1.88 
9.SS b 2.45 to.01 1.98 
7.54- 2.18 t 0.10 2.36 
10.21- 1.39 t 0.03 1.82 
6.03- 1.34 t 0.08 1.64 
10.64 - 1.63 t 0.01 1.69 
6.99- 2.17 ± 0.05 2.20 
8.49- 2.59±0.08 2.28 
9.98- 1.42±0.05 1.88 
S.23- 0.77 ± 0.05 1.09 
6.72- 0.93 ±0.02 1.32 
8.22 c 2.38 ± 0.02 2.28 or 2.70 
5.46- 2.30 ± 0.01 2.24 
4.20- 1.78 ± 0.03 1.68 
lS.0Se 1.94 ± 0.09 1:67 
9.SS- 1.17 ± 0.01 1.32 
4.81- 1.97 ±0.01 2.24 
5.17- 3.15 ± 0.03 3.16 
13.38 c 3.47 ± 0.10 3.10 

























d Predicted coordination (2.28) and n-stacking (2.70) values are too similar to provide an exclusive interaction. 
This compound has thus been ommited from correlation (figure 2.9). 
e Predicted using MOKA (reference 113) 
The LFER equation (eq. 8) obtained from investigation of coordinat~on and n-stacking 
interactions with Fe(III)PPIX was shown to be moderately accurate in calculating predicted 
association constants of small molecules with Fe(III)PPIX. However, the observed association .-
constants of compounds containing amine donor ligands as well as an aromatic moiety 
(compound 19) did not conform to the expected values for coordination and n-stacking, with 
only n-stacking interactions with fe(III)PPIX observed. It was surmised that this is a result of a 











CHAPTER 2. INVESTiGA TlON OF COORDINATION AND Tr-STACKING INTERACTIONS WITH FE(III)PPIX 
As il lustrated in figure 2.10, in order for IT-stacking interactions to occur once bound, the 
aromatic ring system of a compound must be parallel to the protoporphyrin ring system of 
Fe(II I)PPIX. In the case of nitrogen donor lig,mds, this resu lts in the formation of a sterically 
un favourable semi-eclipsed conformation and is suspected to re arrange to form the more 
favourable anti-periplanar conformation which is thus unable to n:-stack while coo rdinated. The 
observed coordination associat'lon constant obtained for these types of amine compounds was 
simil ar to the predicted contribution from IT-stacking interactions, indicating that the 
coordinated conformation with the aromatic ring system in the anti-periplanar posit ion is the 
less favourable interaction. A simila r result was obtained from 9-aminofluorene, 15, where the 
magnitude of the observed association constant implied that only one interaction was 
occurring. Unfortunately, it wa s unclear as to which interaction this was because the 
magnitudes of the predicted values for coordination and IT-stacking contributions are simi lar. In 
the case of oxygen donor ligands, conformational changes do not occur owing to great er steric 





Figure 2.10. Newma n projections along the C - 0 and C - N bonds of compounds that contain a coordi nating (0 
and N) grou p, boun d to Fe(III)PPIX, as well as an aromat ic Tl -stacking (Ar) group . Unfavourable steric co nfo rmations 
of t he bound ni t rogen donor ligands could result in the formation of an anti perip lanar geo met ry. thus preventing 











CHAPTER 2. INVESTIGATION OF COORDINATION AND n-STACKING INTERACTIONS WITH FE(III)PPIX 
Finally, association constants of 4-aminoquinoline compounds with Fe(III)PPIX also cannot be 
accurately predicted based on the assumption that the only interaction occurring is that of 
n-stacking. Predicted log Kobs values for n-stacking with fe(III)PPIX are in the region of 2.30 log 
units lower than the experimental association constants, indicating that there must be 
additional interactions with Fe(III)PPIX occurring. Possibte interactions that have not been taken 
into account could be favourable charge-charge interactions between the protonated quinoline 
nitrogen and deprotonated propionate side chains of fe(III)PPIX. Schneider and Wang 94 have 
found that such electrostatic interactions have a contribution of about 0.9 log units for singly 
charged molecules. Further investigation is required in order to better understand and quantify 
the effects of these additional interactions. 
2.S Conclusions 
The coordination of pyridines, imidazoles, quinolines and phenolates with Fe(III)PPIX was found 
to be directly proportional to the basicity of the donor ligand. The single lFER relationship 
obtained between pKa and coordinating ability allows for prediction of other compounds 
provided the pKa is known. n-Stacking interacti ns of aromatic compounds containing 6, 10, 12 
and 14 n-electron ring systems with PPIX and Fe(III)PPIX were found to increase with an 
increase in the number of n-electrons. Substituents seemingly made small contributions to 
n-stacking interactions but substituent constants could not be extracted. A decrease in 
n-stacking ability with Fe(III)PPIX relative to PPIX was also observed. A lFER equation describing 
n-stacking interactions with Fe(III)PPIX was derived which enabled prediction of this interaction 
for other aromatic compounds. Predicted coordination and n-stacking association constants of 
compounds containing moieties that could accommodate both these interactions were found 
to be additive and these findings led to the derivation of a lfER equation that can predict the 
associating ability of almost any small molecule with Fe(III)PPIX. Care needs be taken with, 
regard to steric conformations as compounds such as benzylamine, 19, were found to be 
unable to both coordinate and n-stack. In addition, there are other interactions with Fe(III)PPIX 
that seemingly play an important role as the 4-aminoquinoline class of compounds have a 
markedly stronger observed interaction than predicted. Unfortunately, these interactions are 























CHAPTER 3. DESIGN OF NOVEL POTENTIAL J3-HAEMA TIN INHIBITORS 
3.1 Introduction 
With the development of equation 8 (see section 2.5), moderately accurate estimates of 
association constants of simple molecules with Fe(III)PPIX are possible. This provided a platform 
for the identification of potential scaffold molecules that have a strong association with 
Fe(III)PPIX which could be further developed into potential ~-haematin formation inhibitors 
through the incorporation of a hydrogen bonding moiety. Utilising molecular modeling 
techniques, identification of favourable hydrogen bonded conformations with Fe(III)PPIX would 
allow for further refinement and potentially provide compounds with a higher probability of 
inhibiting p-haematin formation. 
3.1 Identification of a scaffold molecule 
In order to identify potential template compounds, a threshold association value needed to be 
established such that only compounds with an associ tion constant value equal to or greater 
than the threshold would be considered. This threshold value would have to be the association 
constant obtained with Fe(lIl)PPIX for the parent structure of a known p-haematin inhibitor 
which was thought to follow the proposed mechanism of action through coordination, 
n-stacking and hydrogen bonding. As previously reported,76 antimalarials and p-haematin 
inhibitors, quinine and quinidine (figure 3.1a), are thought to follow the hypothesised 
mechanism of action and thus the parent structure 4-quinoline methanol, 22, (see figure 3.1b) 
was selected to provide the threshold association value. 
a b 
quinine: 8S, 9R 
quinidine: 8R, 9S 
4-quinoline methanol, 22. 
Figure 3.1. (a) Active f3-haematin inhibitors quinine and quinidine, contain coordination (hydroxyl), n-stackin~ 
(quinoline ring) and hydrogen bonding (tertiary amine) moieties that support the hypothesised mechanism of 












CHAPTER 3. DESIGN OF NOVEL POTENTIAL P-HAEMA TIN INHIBITORS 
Unfortunately, compound 22 is not available commercially but it was obtainable by synthetic 
means through a simple, one step reduction reaction of the commercially available starting 





(i) NaBH4, EtOH, RT, 1.5 h. 
The reaction proceeded, using the procedure reported by Hartner et 01. 114, under mild 
conditions to give the required product, 22, in a moderate yield (67%) which was characterised 
using infrared (IR), NMR and mass spectrometry (see chapter 7 for synthetic details). The 
association constant with Fe(III)PPIX was determined as described in chapter 2 and the 
measured value found to be 3.47 ± 0.10 log units, which was set as the threshold association 
value. This observed value was slightly higher than the predicted value of 3.10 ± 0.25 but is not 
statistically different. 
Various simple compounds were then screened as potential scaffold molecules using the 
following criteria. Suitable compounds preferably should: (1) contain a benzyl alcohol moiety; 
(2) contain at least a 10 n-electron aromatic ring system; (3) have a rigid structure to ensure 
preorganisation; (4) have a predicted association constant greater than or equal to 3.47 log 
units; (5) be commercially available for measurement of association constant; (6) produce no 
isomers upon modification; (7) have a commercially available precursor which is inexpensive 











(HAPrER 3. DESIGN OF NOVel POTENTIAL P-HAEMATIN INHI/;lITO RS 
Th e most suitable molecu le identified as a potential scaffold was 9-hydroKyflu orene which mel 
all th e imposed criteria. This commerci ally available molecule con tains a benzyl alcohol moiety 
and a 12 n-e lectron aromati c ring system which have <I connectivity that produces a rigid 
structure. In fact, molecular modelling indicated that th e rigid structure provided optim il l 
n-st acking intera ctions once (Oord inilt ed to the iron cent re of Fe(III)PPIX, as illust ra te d in figure 
3.2, and thus provide il prcorganisational feature that may increilse assoc-iillion interact ions. In 
addit ion, owing to the moleculilr symmetry of this compound, substitution at the 9 posit ion of 
the ring system would give rise to favourable achri al products that could be synthesised from 
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a b c 
Figure 3.2. Molecular structure of template compounc 9·hydro)(yfluorene (a) and lowest energy (;onformations of 
template compound (green) bound to ~e(III ) I' f>I ;'; (b and c). Conformat ions Indic3te filvour3ble II-stacking 
interac tions (lfe possible between fluorene and PPIX ring 5yst em5 with a measured interplanar dist ance of 3.23 A. 
For clari l'V, hydrogens have not been s, own. 
The predicted association constant of 9-hydroxyfluoren e was calculated as 3.33 ± 0.27 using 
equation 8. While this is sl ightly smaller than th e threshold va lue, it was still consid ered owing 
to the larger er ror in the predicted pK" value for the hydroxyl moiety (14.33 ± 0.52. predicted 
using MOKA software J13) wh ich held the possibilit y for a sligh t ly st ronger association constant 
that would be closer to the threshold va lue. Since 9-hydroJ(yfluorene is commercially available. 
the observed association constant was ab le to be determined and fou nd to be 3.64 :t 0.09 log 
un it s, which is greater than the threshold value. 
It is because of these important properties of 9-hydroxyfluroene as well as the fact th at thi s 
compound is not a known antima laria l class that 9-hydroxyfluorene was selected as th e as the 











CHAPTER 3. DESIGN OF NOVEL POTENTIAL P-HAEMA TIN INHIBITORS 
3.3 Incorporation of a hydrogen bond donor moiety 
With the template molecule chosen to act as the anchor moiety of the proposed inhibitor, 
hydrogen bonding groups were incorporated into the structure. As detailed in section 1.10.3, 
there are a variety of hydrogen bonding groups that provide favourable interactions with 
carboxylic acids and carboxylate anions, with guanidine moieties being one of the strongest 
owing to the ability to form bidentate hydrogen bonds and the stabilising presence of a salt 
bridge. It was for these reasons that the guanidine moiety was selected as the hydrogen 
bonding feature. In order to provide a comparison with the stronger guanidine group, a primary 
amine moiety was also included as a hydrogen bond donor. 
The incorporation of this amine group required no additional synthesis, as formation of the 
guanidine moiety required a primary amine as an intermediate compound (see chapter 5 for 
further details on synthesis). In addition a 1,3,5-azaadamantane moiety was also proposed as a 
possible hydrogen bond donor because the cage-like structure provided a preorganisation 
feature, similar to that of quinine and quinidine antimalarials, which was thought to possibly 
playa significant role in the proposed mechanism of action. 
Attachment of the hydrogen bonding moieties to the anchor template molecule, 
9-hydroxyfluorene, required a carbon spacer and molecular modelling identified favourable 
hydrogen bonding interactions of the guanidine moiety and azaadamantane moiety were when 
the alkyl linker was one or two carbons in length. Thus, compounds A to E were proposed for 
investigation (see figure 3.3). 
A B c D E 











CHAPTER 3. DESIGN OF NOVEL POTENTIAL I3-HAEMATIN INHIBITORS 
3.4 Molecular modelling of proposed inhibitor/Fe(III)PPIX complexes 
Molecular mechanics and dynamics (with simulated annealing) modelling of the proposed 
compounds bound to the iron centre of Fe(III)PPIX provided an additional method with which 
to determine the feasibility of these compounds as potential ~-haematin inhibitors. While this 
technique is not able to directly compare energies between comple~s, the modelling provides 
an insight into the conformations of the bound compounds and allows for the identification of 
favourable and unfavourable conformations of the complexes. Should these lowest energy 
conformations have the possibility of an intramo~cular hydrogen bond interaction with the 
propionate side chain, the energy of the hydrogen bonded conformation could then be 
compared to the lowest energy conformation and insight into whether the possibility exists for 
a favourable hydrogen bonded interaction could be obtained. 
Unfortunately, this technique cannot provide conclusive results because the modelling was 
performed in vacuum and effects of hydration were not taken into account. This is a signifICant 
drawback as interactions between Fe(III)PPIX and proposed compounds are thought to occur, in 
part, in the aqueous digestive vacuole of the parasite. However, the results obtained from 
modelling are still of interest as these interactions are also believed to occur in lipid 
nanospheres within the digestive vacuole.39 Because of the absence of water, this lipid 
environment is likely to resemble the vacuum model more closely and thus the results obtained 
may have some validity for this situation. In addition, the modelling does indi<:ate the feasibility 
of proposed compounds forming the required interactions. 
3.4.1 Compounds A to D. 
Proposed compounds A to 0 were bonded to the iron centre of Fe(III)PPIX and lowest energy 
conformations for the complex were obtained. All compounds were observed to have' 
favourable It-stacking interactions with the porphyrin ring system, and in particular, favoured 
the a carbons of the pyrrole rings of the porphyrin system. Conformations of all compounds are 











CHAPTER 3. DESIGN OF NOVEL POTENTIAL j3-HAEMA TIN INHIBITORS 
A B 
, 
c 't---- D 




Figure 3.4. Molecular mode lling of compounds A to D indicating th e more favourabl e hydrogen bond 
conformations of the guanidine derivatives, B and D, For clarity, all hydrogens except those of the hydrogen 
bond donors have not been shown. 
Guanidine derivatives, Band 0, displayed conformations which provided for favourabl e 
hydrogen bonding interactions, w ith small energy differences of 3.75 and 3,90 kJ/mol, 
respectively, between the hydrogen bonded and lowest energy conformations. The low energy 
requirement for the formation of a hydrogen bonded conformation indicated that these 
compounds were good candidates for ()-haematin inhibition. While the lowest energy 
conformation of the complex allowed for favourable hydrogen bonding interactions to occur, 
the flexibi li ty of the alkyl linker provides for other conformations, similar in energy, which do 












CHAPTER 3. DESIGN OF NOVEL POTENTIAL P-HAEMATIN INHIBITORS 
Amine precursor A was found to have a lowest energy conformation where the hydrogen 
bonding moiety directed away from the propionate side chain. Forcing a hydrogen bonded 
interaction resulted in a large increase in energy, 8.04 kJ/mol relative to the lowest energy 
conformations, and a significant distortion of the protoporphyrin ring was also observed. This 
suggested that compound A was not a good potential candidate for f3-haematin inhibition, but 
would provide for an interesting comparison with compounds Band D. 
The amine pr.ecursor C was found to adopt a similar conformation to that observed with 
compound A but the length of the hydrogen bonding linker did not allow for distances 
conducive for hydrogen bonding interactions. This compound was retained as a proposed 
negative control. 
3.4.2 Compound E. 
Molecular modelling of the azaadamantane derivative, compound E, was performed as for 
compounds A to D. In this case, the added rigidity of the structure allowed for the calculation of 
an energy map of the complex. Rotating torsion angles <I> and liJ, see figure 3.5a, and recording 
the conformational strain energy of the complex after each rotation, favourable and 
unfavourable energy regions could be identified (see figure 3.5b). Comparing the torsion angles 
of the hydrogen bonded conformation to the energy map of the complex indicated that this 
compound was seemingly preorganised to partake in hydrogen bonding interactions with the 
propionate side chain once bound, as the torsion angles of the hydrogen bonded conformation 
were very close to the torsion angles of the lowest energy conformation of the complex. Thus 
the preorganisation of this compound was thought to provide an interesting comparison to the 
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Figure 3.5. (ilJ Hydrogen bonded conformation of compound E bound to Fe(1I1}PPIX. Torsi on ;mgl es 4> and w used 
to ca lculCite an energy map of th e compleK are shown in green and pink, respectively, All hydrogens apart from 
tho, e of th e hydrogen bond ing group; h ~ve been removed :or cI~rity (b) Energy mJP o f thf' compound E 
Fe(III )PPIX co mplex, light blue areas ind icate low energy (onformation 5 while red areas indicate hleh enerp,y 
conformations The diagram indlcilt~ that the torSion <lngle5 of the globill eneTgy minimum (dark blue ci rcle) 











CHAPTER 3. DESIGN OF NOVEL POTENTIAL IJ-HAEMATIN INHIBITORS 
3.5 Conclusions 
Using equation 8, derived in section 2.4, association constants for a range of molecules that 
could both coordinate and n-stack were pr€dicted. The association constant of 4-quinoline 
methanol, the parent structure of the antimalarials quinine and quinidine, was chosen as a 
threshold value and the compound was synthesised. Predicted association constants, obtained 
from equation 8, that were greater than or equal to the threshold minimum (measured as 3.47 
± 0.10) were then only considered. The commercially available compound 9-hydroxyf1uorene 
was chosen as the template molecule as the predicted association constant (3.33 ± 0.25) and 
experimental value (3.64 ± 0.09) obtained were similar to that of the thr€shold minimum. 
The .guanidine moiety was selected as the hydrogen bonding group and a one and two carbon 
linker was selected to attach it to the template molecule at the 9-position of the fluorene ring. 
Synthetic precursors to guanidines are amine moieties which were also considered as proposed 
compounds in order to compare the strength of hydrogen bond interaction. An additional 
azaadamantane moiety was also proposed as a potential target molecule because of the rigidity 
of this class of compound, which was thought to have a similar preorganisation feature as 
quinine and quinidine. In total, five compounds (A to E) were proposed. 
Molecular mechanics and dynamics (with simulated annealing) modelling was performed on 
the proposed inhibitor/Fe(III)PPIX complexes in order to identify favourable conformations that 
may support hydrogen bonding interactions with the propionate side chain. It was found that 
the guanidine derivatives (8 and D) could form favourable hydrogen bonded conformations in 
vacuum but because of the flexibility of the linkers, preorganisation was unlikely. Amine 
precursor A was found to have a conformation where the hydrogen bonding group was 
directed away from the propionate side chain and required a large iocrease in energy to form a 
hydrogen bond€d conformation under vacuum conditions. Compound C was unable to form a 












CHAPTER 3. DESIGN OF NOVEL POTENTIAL P-HAEMATIN INHIBITORS 
Azaadamantane derivative E was found to have a lowest energy conformation that allowed for 
hydrogen bonding interactions. In addition, because of the rigidity of the complex, an energy 
map of the complex could be determined and it was found that this compound is preorganised 
to hydrogen bond as the hydrogen bonded conformation is very similar to the lowest energy 
conformation. Thus compound E was retained to compare this possible preorganisation feature 























CHAPTER 4. SYNTHESIS OF PROPOSED P-HAEMATIN INHIBITORS 
4.1 Introduction 
By investigating coordination and n-stacking interactions with Fe(III)PPIX (see chapter 2), five 
compounds (A to E) were proposed (see chapter 3) based on a 9-hydroxyfluorene scaffold. The 
details of their attempted synthesis and isolation are presented below. 
4.2 Synthesis of 9-(2-aminoethyl)-fluoren-9-ol, A 







Ring opening Epoxidation o 
====~~ ~ 
25 26 27 
The synthesis of compound A was envisaged to be achieved through the reduction of the 
nitrile, 25, which in turn could be obtained from the nucleophilic attack of cyanide at the least 
substituted carbon of epoxide 26 in a ring opening step. Because of steric hindrance, formation 
of the regioisomer of compound 25, 9-(hydroxymethyl)-fluorene-9-carbonitrile, was deemed 
unlikely as this would require attack by the cyanide nucleophile at; the more sterically 
unfavourable quaternary carbon of the epoxide. Finally, synthesis of epoxide 26 was envisaged 
to occur via the Corey epoxidation115 of the commercially available 9-fluorenone, 27. 
Compound A was' successfully synthesised from the starting material 27 based on the 
retrosynthetic scheme detailed above. Reaction conditions for the formation of compound A. . 





















(i) 1. NaH, TMSOI, DMSO, N2 atm, 25 DC, 30 min. 2. 9-Fluorenone, 25 DC, 1.5 h. 
(ii) NaCN, NH4CI, MeOH/H20 (8:1), 25 DC, 14 h. (iii) LAH, Et20, 0 DC to 25 DC, N2 atm, 20 h. 
4.2.1 Synthesis of SpiroUluorene-9,2'-oxirane], 26. 
A 
A Corey epoxidation of 9-fluorenone,-27, was requk:ed to form the target spiro epoxide, 26. The 
reaction involves the conversion of trimethylsulfoxonium iodide (TMSOI) to the corresponding 
methylene intermediate 28, through proton abstraction by sodium hydride on one of the 
TMSOI methyl groups. This intermediate is activated towards nucleophilic attack on the 
carbonyl group of compound 27 to form 26 with dimethylsulfoxide (DMSO) and sodium iodide 














CHAPTER 4. SYNTHESIS OF PROPOSED P-HAEMATIN INHIBITORS 
The reaction was carried out under mild conditions, following a procedure of a similar 
reaction116, yielding a product identified by NMR spectrometry as compound 26. Appearance of 
peaks in the lH spectrum at 3.71 ppm and 13e spectrum at 54.9 ppm were the key identifiers of 
compound 26 as they were the peaks assigned to the methylene group (position 2' in figure 
4.1) ofthe epoxide. 
a 
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Figure 4.1. (a) lH NMR spectrum of compound 26 with characteristic methylene peak occurring at 3.71 ppm. 
Inset. Expanded aromatic region. (b) 13C NMR spectrum of compound 26 showing the indicative methylene peak 
at 54.9 ppm. Inset. Expanded region showing quaternary carbons 10, 11, 12 and 13. Asterisk denotes CDCI3 
solvent peaks. 
Yields obtained for the formation of compound 26 were satisfactory (63%) and the product 
obtained was deemed pure enough for use in subsequent steps. It should be noted that this 
compound was not stable over time and increasing the reaction temperature to 40 °e resulted 
in a large amount of by-product formation. Thus subsequent reactions with this compound had 











CHAPTER 4. SYNTHESIS OF PROPOSED !3·HAEMATIN INHIBITORS 
4.2.2 Synthesis of (9-hydroxy-fluoren-9-yl)ocetonitrile, 15. 
The nitrile 25 was synthesised from a crude mixture of the spiro epoxide 26, using the mild 
conditions reported by Chini et 01. 117, to give the required product in moderate yields (65% over 
2 steps), with the identity of the product confirmed using infrared (IR), NMR and mass 
spectrometry. The IR spectrum revealed a characteristic peak corresponding to the nitrile 
moiety at 2257 cm·l , while shifts of the methylene peaks in both the I H and HC NMR spectrum 
as well as the appearance of the quaternary carbon (Cg in figure 4.2) of the nitrile moiety 
indicated successful target product formation (see figure 4.2 for NMR shifts). 
a 
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Figure 4.2: (al 'H NMR 5pectra of compound 26 (top) and compound 2S (bottom) comparing shifts in methylene 
and aromatic peaks. Insets. Expanded aromatic reg ion. Inset. Expan5ion showing quaternary and methylene 
carbons 2' and 15. (b) "e NMR 5pectra of compound 26 (top) and compound 25 (bottom) showing shifts in 
methylene peaks. Insets. Expansion showing quaternary and methylene carbons 9 and 15. Asterisk denotes 











CHAPTER 4. SYNTHESIS OF PROPOSED j3-HAEMATIN INHIBITORS 
4.2.3 Synthesis of 9-{2-aminoethyl)-fluoren-9-01, A. 
The synthesis of amine A required the reduction of the nitrile 25, which was achieved using 
lithium aluminium hydride (LAH). The reaction proceeded as detailed earlier in scheme 4.2 and 
produced a large variety of unwanted by-products. The temperature was lowered and kept at 
o °c in an attempt to reduce the formation of these side products. However, lowering the 
temperature resulted in no reaction occurring. Increasing the temperature slowly from 0 °c, 
keeping it below 10°C, did not lessen the extent of by-product formation and so the reaction 
was left overnight to stir at 25 0c. Nevertheless, even with the by-product formation, yields 
obtained were satisfactory (68%) and so no further attempt at decreasing the side product 
formation was attempted. Instead it was purified using column chromatography. 
The product obtained was confirmed as compound A by comparing the lH and 13C NMR spectra 
of the starting material and product, shown in figure 4.3. The disappearance in the proton 
spectrum of the singlet peak at 2.98 ppm (ascribed as H-14 of compound A) and appearance of 
two triplet peaks at 2.03 and 2.68 ppm (ascribed as H-14 and H-15 in compound B) were 
indicative of the formation of the two carbon chain. Both these methylene carbons were seen 
in the 13C spectrum at 38.0 and 44.0 ppm. In addition, the IR spectrum showed the 
disappearance of the nitrile peak observed at 2257 cm-1 in the starting material and mass 
spectrometry confirmed the formation of compound A. 
With the successful synthesis of A, synthesis of compound B could be attempted utilising 
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Figure 4.3: (a) 'H NMR spectra of compound 25 (top) and compound A (bottom) comparing changes in 
methylene and shifts In aromatk peaks. Insets. Expanded aromatic region. (b) "c NMR spectra of compound 25 
(top) and compound A (bottom) showing shifts and appearances of methylene peaks. Asterisk denotes CDC!, 
and water solvent peaks. Baseline impurities in compound B are ascribed to minor solvent contamination f rom 
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4.3 Synthesis of 1-[2-(9-hydroxy-fluoren-9-yl)ethyl]guanidine, B 
The retrosynthetic pathway developed for the synthesis of the guanidine derivative, B, is shown 





The envisaged synthesis of compound B required the guanytation of compound A utilising a 
suitable guanylating agent. The commonly used guanylating agent 3,5-dimethylpyrazole-l-
carboxamidine nitrate (OpeN), 29, was chosen which would undergo nucleophilic attack from 
the primary amine of compound A resulting in the formation of target product, compound B, 
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The synthesis of the guanidine derivative, B, was succ~ssfully performed, according to a general 
procedure reported by Yedavalli et 01.118, by reacting the guanylating agent OPCN and primary 
amine, A, under relatively mild conditions, detailed in scheme 4.6, to give the corresponding 




(i) opeN, MeOH, reflux, 14 h. 
While the reaction proceeded with relative ease to give the required product, isolation and 
purification was somewhat challenging. Owing to the tendency of guanidines to tail on silica 
columns, some impurities from the reaction co-eluted with the required product after 
purifICation by column chromatography. Unfortunately, the use of bases such as triethylamine 
(TEA) and ammonium hydroxide in the eluent system did nothing to limit this effect and in 
ord~r to obtain the product in high purity, the compound was subjected to numerous rounds of 
purification by column chromatography (see chapter 7 for details). The target product was 
eventually isolated in a moderate yield (64%) and identified as compoul'}d B by IR, NMR and 
mass spectroscopy. Methylene peak shifts in the lH and 13C NMR spectra (see figure 4.4) 
indicated th~ product was significantly different from t~ starting material, A. Confirmation of, 
the required guanidine formation was obtained from th~ IR spectrum of the product. 
Comparing this IR spectrum to that of guanidine hydrochloride and starting material, A, (see 
figure 4.5), a peak indicative of a guanidine moiety was observ~d at 1665 cm-l in compound B 
but was not present in compound A. 
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Figure 4.4: (a) lH NMR spectra of compo und A (top) and com cound B (botto m) comp.Jring shilts in melh V1pnil 
peaks. Insets. E~p,mded aromatic and al iphatic regions. (b ) Be NMR spew a 0< compound A !top) and compound 
B (boHom) showing ~hifg of methylene peaks. Insets. Expanded region showing qU<"ltern<"lry (arbon 9. Aster isks 
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Figure 4.5: Infrared 5pe<t ra of $tart ing mater ial A, gU<"Inidine He! and product B, indicat ing the presence of 
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4.4 Synthesis of 9-(aminomethyl)-fluoren-9-ol, C 
The synthesis of compound C was investigated using two different routes, as the first route 
failed to produce the required product. A second route was then developed which led to the 











The retrosynthetic analysis of compound C (see scheme 4.7) was initially envisaged to follow a 
similar pathway as the one developed for compound A (see section 4.1), where the required 
primary amine would be obtained through the reduction of nitrile group. The synthesis of the 
required nitrile, 30, had been previously been reported in the Iiterature119, 120 where the use of 
nucleophilic attack by trimethylsilyl cyanide (TMSCN) on the carbonyl of fluorenone, 27, 
resulted in the target product being obtained. Reduction of the nitrile would result in the 
simultaneous deprotection of compound 30. 
While compound 30 was synthesised under the conditions described in scheme 4.8, 
unfortunately, reduction of the nitrile group to form the primary amine moiety failed to occur. 
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Scheme 4.8: 
0 TMSO eN HO NH, 
I 
r' '" 
(i) r' ~ Y '" 
(i i) ;/ ~ y '" • * 27% ,,~ ~ ~ ~ ~ -
27 30 C 
(i) TMSCN, 11, o eM, N1 atm, RT. 2h. (iiJ LAH, THF, N1 aim. a °c to RT. 2<1- h. 
4.4.1 Synthesis of 9-[(trimethylsilyl}oxyJ-fluore ne-9-carbonitrile, 30. 
As mentioned above, t he synthesis of compound 30 had been well described in the 
literatLJre.ll9· 120 The mechan ism of formation involved the use of a lewis acid in order to 
act ivate the carbonyl group of compound 27 toward nucleophil ic. attack of the nit ril e. The 
reagent used in the synthesis of th e t itle compound was TMSCN. which has both a lewis add 
(TMS) and nucleophi li c (CN) moiety t hat provide for an efficient method of nucleophilic 
addition. While the reaction proceeded under fairly mild cond itions with a relatively short 
reaction tim e to produce compou nd 30 in high pur ity, unfortun ately low yields were obtained 
(27%). The appearan ce of an additional quaternary carbon peak at 120.2 ppm in the BC NMR 
spectrum indicated the product obtained was different from the starting material, 27. The 
appearance o f a nitrile peak at 2238 cm ! in th e in frared spectrum (see figure 4.6) that 
confirmed the form ation of compound 30. 
Fluorenone 
Compound 30 ~'-_"-_ 
3600 3300 3000 2700 2400 2100 1800 
ppm 
Figure 4.6: IR spect rum oi lluorenone, 27. and compound 30 indlc.ltlng the ilppearan:::e in the product of a 
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The following step in which the amine, C, would be obtained from the nitrile required the 
reduction of compound 30 with lithium aluminium hydride (LAH), which would both reduce the 
nitrile to the amine as well as remove the trimethylsilyl, TMS, group from the alcohol. It was at 
this point that the synthetic route failed, and the target product was not obtained. At the time, 
it was thought that the harsh reducing conditions of this reaction led to the formation of a 
variety of side products instead of the required product. It was later discovered that the LAH 
reagent used was not active and thus did not reduce the nitrile as it should have. Because of 
this apparent non-reactivity and fragile nature of the ~-amino akohol, C, coupled with the low 
yields obtained, route 2 was devised in an attempt to circumvent these problems. This 
approach incorporated seemingly milder reducing conditions to obtain the amine and the use 
of compound 26 as an intermediate which was already well established from previous reactions 










The retrosynthetic pathway of route 2, shown in scheme 4.9, was developed in an attempt to 
bypass some of the problems experienced in route 1 (detailed above). The reduction method 
chosen for its milder reaction conditions was that of the Staudinger reaction121, whereby azide 
31 (formed through ring opening of compound 26) would be converted to the target primary 















(j) ~ii) - -93% 64% 
(crude) 
26 31 C 
m NaNg, NH4CI, MeOH/H20 (8:1), RT, 16h. (ii) PPhg, MeCN/H20 (7:1), RT, 14h. 
4.4.2 Synthesis oj 9-(ozidomethyl)-Jluoren-9-01, 31. 
Compound 31 was obtained through a ring opening reaction where the azide group of sodium 
azide was delivered to the less sterically hindered carbon of the epoxide ring. The reaction 
proceeded under the mild conditions reported by Benedetti et 01.122 to produce compound 31 
in high yields (93%) which was characterised using IR and NMR spectrometry. The IR spectrum 
of the product identified characteristic peaks corresponding to the azide and alcohol moieties 
(2106 and 3392 cm-1 respectively). While the 1H NMR spectrum (see figure 4.7) showed a small 
shift in the methylene peaks from 3.70 ppm in the starting material to 3.85 ppm in the product. 
Shifts in the 13C spectrum were more convincing of product formation, where the methylene 
carbon peaks shifted from 54.9 to 68.0 ppm. 
It was initially thought that the tertiary alcohol of compound 31 needed to be protected before 
the Staudinger reduction step with triphenylphosphine, PPh3, was attempted. Unfortunately, all 
attempts at protecting the alcohol with benzyl bromide failed. The rationale behind the inability 
to protect the alcohol was that the protecting group was too bulky for the reaction to take 
place. This meant that it was even more unlikely that the bulkier PPh3 reagent would be able to 
react with this alcohol moiety and so the Staudinger reduction was performed on an impure 
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Compound C was synthesised from t he azide, 31, via a Staudinger react ion fo llowing literatu re 
procedures where PPh) was added to an azide in the presence of a tertia ry alcohol . The 
















The phosphorus of PPh3 attacks the nitrogen of the azide to form the phosphazide 
interrTl€diate. Nitrogen gas is then released to form the iminophosphorane intermediate which 
is then hydrolysed by water to produce the target amine as well as triphenylphosphine oxide as 
a by-product. 
The reaction proceeded under mild conditions to give compound C in a moderate yield (64%), 
with the absence of azide peak at 2106 cm-1 in the IR spectrum of the product supporting the 
formation of the required compound. IH and 13e NMR spectra (shown in figure 4.8) showed 
slight shifts in the methylene groups of the product (3.70 and 69.2 ppm respectively) as 
compared to the starting material (3.85 and 68.0 ppm respectively) and mass spectrometry also 
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With the required primary amine, C, successfully obtained, -;ynthesis of the corresponding 
guanidine target, 0, was then attempted. 
4.5 Attempted wnthe~i~ of 1-[(9-hydroxy-fluoren-9-yl)methyl)guanidine, D 
The synthesis of the guanidine 0 required the guanylation of the primary amine of compound C 
and because of variou> reilsons, detililed further on, three different guanylating agents (29, 32 
ilnd 33 in ~heme 4,12.) were used in the attempted synthe>is of compound D, While the 
formation of compound D was confirmed by mas, ~pectrometry, unfortunately this compound 























(i) 29, Tea, BOH or DMF/H20 (1:1). (ii) 32, MeOH or EtOH. (iii) 33, TEA, MeOH or EtOH. 
3,S-Dimethylpyrazole-l-carboxamidine nitrate (DPeN), 29. 
33 
As with the formation of compound B, the commonly used guanylating agent, OPCN, was 
initially employed in the attempted formation of compound D. Initially the reaction was carried 
out under the same conditions as those employed in the synthesis of guanidine, B. Thin layer 
chromatography (TLC) indicated that the reaction was not successful. In an attempt to promote 
the formation of the required product, reaction conditions were varied and the base TEA 
introduced to aid dissolution of compound A in the solvent system as well as neutralise the salt 
of the product formed. The reaction temperature was also increased from 40°C to 80 °c and 
the mixture left for 5 days to react. Even after this, TLC still indicated no product formation had 
occurred and so the solvent system was changed to OMF/H20 (1:1) to gauge whether solvent 
interaction may playa significant role in the reaction. Unfortunately, this still resulted in no 
product formation. Reaction mixtures were then subjected to microwave irradiation (150 W at 
40°C, 80 °c and 100°C for 10 minutes per irradiation) in an attempt to provide a more effective 
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It was reasoned at this point that perhaps there may be steric hindrance experienced by the 
short chain primary amine and thus nucleophilic attack at the Sp2 centre of the carboxamidine 
of opeN would be difficult to attain. The smaller guanylating agent, cyanamide, was then 
substituted for opeN as this was less likely to encounter these presumed steric hindrances. 
Cyanamide, 32. 
Compound C was reacted with cyanamide under the conditions detailed in scheme 4.13, but 
product formation was still not observed. Since the smaller cyanamide was unable to produce 
the required guanidine, it was then suspected that steric hindrance may not be the sole reason 
behind the failure of this reaction. A second possible explanation was then postulated as being 
the existence of an intramolecular hydrogen bond between the primary amine and tertiary 
alcohol moieties of compound C. Assuming this to be the case, the lone pair of the primary 
amine nitrogen atom of compound C would then be involved with the hydrogen bond and thus 
have reduced nUcleophilicity. In addition, the predicted pKa of the compound was calculated as 
5.97 ± 0.40112 which is significantly lower than expected for a primary amine moiety. The low 
nucleophilicity and possible presence of an intramolecular bond is a likely explanation for the 
lack of reactivity of this compound. 
A literature search for alternate guanylating agents was then undertaken and a paper by Wit yak 
et al.124 was found, in which similar problems with intramolecular interactions were 
experienced where guanidine formation using OpeN and cyanamide was prevented. The paper 
described the use of formamidinesulfonic acid (FSA), 33, as an alternate reagent which was 
more reactive and resulted in the formation of their required guanidine. With this success in 
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FOfmUmidinl!5ulJonic; u,id (FSA), 33. 
fSA is not a commercia lly available compound and thus had to be synlhesised. Lileratureu.; 
reports ind icated that this reagent Wa5 e~si l v obtained by the ox idJt ion of the commercia lly 
available slarting materia l. formamid incsul f inic acid. 34. using peracetic acid. Reaction 
cond itions used Me detai led in scheme 4.13. 
(i I 
• 
{il CH , CO,H. CH,CO,H. 10· 20 "c. 3h. 
IR 5pectroscopy was used to confirm the formation of the required sul fonic acid with 
characterist ic pea ks for this mOiety appearing at 1227 and 1054 em ', Comparison of the 
spectrum of 5tarting mater ial, 34, to product 33 (see figure 4.9) revealed no peak5 
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Figure 4.9: I R ,pectra of 'larti n~ m"t""'ial, form,mid ine,ulfinic acid {34, biliel. and product. formamiditw5u lfon ic 
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With the formation of formamidinesulfonic acid successful, guanylation of compound C was 
then attempted, whereby the guanylating reagent, TEA and primary amine, C, were left to 
reflux in methanol. After 45 hours, no product formation was observed. The reaction mixture 
was then subjected to microwave irradiation (150 W) at 80°C and 100 °c for 10 minutes each, 
but still produced no identifiable product by TlC analysis. 
As TlC is not always a reliable method of product identification, the proton NMR spectrum of 
all reaction mixtures was taken. No discernable shift in the methylene peak was observed. Mass 
spectrometry was then used to identify the possibility of product formation by investigating 
whether a mass peak corresponding to the product was present. The mass spectra of the 
reaction mixtures were taken and all were found to have a peak corresponding to the target 
product (254 m/z) as well as the starting material (212 m/z). This indicated that the reactions 
had proceeded albeit to a far lesser degree with yields that would not practically afford the 
desired product. 
In an attempt to isolate any compound D formed, separation of impurities and starting 
material, using column chromatography, was undertaken. Unfortunately, owing to the large 
amount of by-products and unreacted starting material in the reaction mixture, compound D 
could not be isolated as it was presumably present in minute quantities compared to 
by-products. Because of this difficulty in isolation, apparent low yield and time constraints, the 
synthesis of this compound was abandoned in favour of the synthesis of the final proposed 
compound E. 
While the isolation of compound D remained elusive, mass spectrometry indicated the 
synthesis of this compound was indeed possible. With more time to vary reaction conditions in 
order to improve presumably low yields, as well as access to equipment such as preparative 
HPlC, the possibility remains that this compound could yet be isolated and tested for 
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4.6 Attempted synthesis of 9-(7-methyl-l,3,5-triaza-adamantanyl)-fluoren-9-ol, E 
The retrosynthetic pathway developed for the synthesis of the title azaadamantane derivative 







=~)- ~ + 
35 
~ Grignard 
~N Bromination~ ('-(N I:N -c I N N--.I N--.I NH2 Br 
37 36 
The first retrosynthetic step in the formation of compound E, required nucl.eophilic attack of 
the Grignard reagent, 35, formed from 7-bromo-1,3,S-triazaadamantane, 36, at the least 
substituted carbon of the spiro epoxide, 26. Because of the steric bulk of compound 26, the 
regioisomer, [9-{1,3,S-azaadamant-7-yl)-fluoren-9-yl]methanol, was deemed unlikely to form as 
this would require the nucleophilic attack to occur at the more unfavourable, quaternary 
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Wh ile formation of thf' abovf' mC!ntion ed G ri g n~rd reagent had never previously been reportf'd. 
th e synthesi s of the required bromo intermediate 36 from the commercially availab le stMting 
material hexamf'thy l e net~tramin e. 39. h3s been claimed in a patent by WiNf'r 1 " 
Hexamethylenet~tramine undf'rwent nitration to form the nitro intermedi~te. 38, which W3S 
t il f'n reducf'd to thf' corresponding pri ma ry ~mine intermediate, 37. lhe final step involved thf' 
brom inat ion of compound 37, to give 7-bromo- l.3.S ·tri ala~damantane. 36. The synthesis of 
tile requ ired spiro epoxide. 26. was a l re~dy well est3b lished and il detailed in sect ion 4.2..1. 
Synthelis of the required al~~d~mant~ne intermed iat es w~s 3ccompli shed undf'r relatively 
mi ld conditi ons with moderate yields obta in f'd (Sf'f' scheme 4.15) Unfortunately, t he fin 31 
coupling stf'P involving nucleop hilic 3ttack by the Gr i gn~rd re3gent on epoxide, 26, fa iled to 
produce the target compound E. Detail , of ttlf' ,ynthesis of th e 31aadamantane in termedi3tes 
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4.6.1 Synthesis of 7-nitro-1,3,5-triazaadamantane, 38. 
The synthesis of compound 38 had been described for industrial use in a patent by Wiezer126, 
which involved the reaction between hexamethylenetatramine, 39, and nitromethane. The 
mechanism of formation of 38 was proposed by Kuznetsov et al. 127 and is described in scheme 
4.16, below. This mechanism was based on a modification of the Mannich reaction, where 
hexamethylenetatramine serves as both the ammonium and methylene element, while 









rl~ ~ - (q~ -N---\ \:=N---\ 
38 
The patent by Wiezer126 provided a number of varying conditions for the formation of 
compound 38, which could be essentially divided into two categories: (a) using a primary 
alcohol, where C = 1 to 4, as a solvent or (b) using the acid component as a solvent. The patent 
also clearly stated that water contamination needs to be kept to a minimum, preferably not 
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Owing to the hygroscopic nature of the acid component, glacial acetic acid, it w~s initially 
d~c,d~d to u,e cat~gory (~), with butanol as the ,olvent, in order to keep th~ amount of Jcetic 
acid and water contamination to a minimum. Upon completion 01 the reaction, a dark black 
'y,up was obtained, indicating that a large ~mount of by-product had formed. Eventually, 
through copious washings and a recrystali5olt ion from wolter, J cream coloured precipitate was 
obt"ined in a low yield (12%), which w"s identified as product 38 throu(lh NMR ~nd ma" 
spectrometry. 
Because of its ~ymmetry, the start ing material hexamethylenetatramine, 39, only has J single 
-- 1) peJk in both the'H Jnd C NMR spectra. Breaking the 'ytlllnet,y of 39 by the rt'movJI of one 
tertiJry amine and in5ertion 01 the nitromethylene group in 38 resulted in the appeJrance of 
thre~ peaks in both ' f! ~nd He NMR. In the proton spectrum (see figure 4.10), the ,inglt't 
obtained integrated lor six protons and the two doublets accounted for three protons each . 
Tht' six prolon~ de,cribed by the 'inglet are "II in the same chemical environm~nt (asoignt'd as 
H1 in figure 4.2). Because of the fused chJir nature of the molecule, the remaining six proton5 
are not all in the ,,,me environment. Each doublet accounts f or three protons that "re in the 
equatorial or axial po~ition (aosigned a5 H, in figure 4,10), The three peak~ in the Be spectrum 
were aS5igned as the two sets of methylene carbons (a05igned a5 pOSition 1 and 2 in figure 4.10) 
"nd the qu~te mary carbon of the inserted nitromethylene group. 
, 
t;:;tJ y l 
NO, 
~ 6 4,5 44 43 
Figure 4.10: 'H NMR 'peCl!u rn (i n LJ,O) of 'ompound 38. fo! dority, az.l"d"monl.lne '!!uclu re ha< nO! !>€-en 
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The melting point obtained for this compound was found to be 183 - 185°C, and could not be 
directly compared to literature values because of the large discrepancies in melting point 
between the various authors. These reported values ranged between 260 °c and 310°C. 128-130 
It was concluded from NMR and mass spectrometry that the correct product had indeed been 
obtained. 
While this method did produce the required compound, yields obtained were low and isolation 
was difficult. Thus formation of compound 38 was then attempted using conditions of category 
(b) described in the patent by Wiezerl21;. Using acetic acid as both solvent and acid component 
resulted in the successful synthesis of compound 38 in a moderate yield (53%) which required 
no further purification for use in the subsequent reduction reaction. 
4.6.2 Synthesis of 7-amino-l,3,5-triazaadamantane, 37. 
The synthesis of amine 37 requir~d the reduction of the nitro moiety of compound 38. 
Kuznetsov et al.127 had previously reported this reaction using Raney Nickel as a catalyst and 
hydrazine as a hydrogen source under fairly mild conditions. Following this procedure, the 
reduction of compound 38 to compound 37 was achieved in moderate yields (61%). Product 
formation was confirmed by the 13C NMR spectrum (see figure 4.11), where shifts in the 
quaternary carbon peak (assigned as C1 in figure 4.11) from 57.4 ppm in compound 38 to 
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C2 4N ~N 1 NJ3) 3 
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Figure 4.11: 13C NMR spectra (in D20) showing quaternary carbon peak shifts of starting material, compound 38 
(top) and isolated product 37 (bottom). 
Since the report of this reaction in 1985, there had been no further mention of alternative 
methods of nitro reduction for this specific compound. A brief survey of alternative reduction 
methods was then undertaken, in which Raney Nickel was substituted for the more commonly 
used palladium over activated carbon (Pd/C) catalyst and altering the hydrogen source 
according to various references131, 132. 
A paper by Ram and Ehrenkaufer131 reported the use of ammonium formate and Pd/C in the 
reduction of aliphatic nitro groups to corresponding amine groups. The synthetic conditions of 
the reported procedure required the reactants to be dissolved in methanol and left to stir at 
25°C. Reported reaction times did not exceed 120 minutes. When compound 38 was subjected 











CHAPTER 4. SYNTHESIS OF PROPOSED J3-HAEMATIN INHIBITORS 
An additional method then employed was the more commonly used reduction technique of 
catalytic hydrogenation utilising hydrogen gas under pressurised conditions. Compound 38 was 
dissolved in a small amount of acetic acid and added to Pd/C in methanol.132 The container was 
charged with hydrogen gas to 3 atm and left to run for 4 hours. Unfortunately, upon workup of 
the reaction, it was discovered that only a small amount of product had formed, leaving most of 
the starting material unreacted. This indicated that the original Raney Nickel procedure was the 
most favourable. Since the second alternative reduction procedure was able to produce the 
required product, albeit in low yields, this may provide a suitable alternative should Raney 
Nickel not be available. Reaction conditions, such as reaction time and temperature, would 
need further optimisation in order to produce potentially higher yields and thus provide a more 
suitable alternative reduction method. 
4.6.3 Synthesis oj 7-bromo-1,3,5-triazaadamantane, 36. 
The bromination of amine 37 to form compound 36 was reported in the same Kuznetsov 
paper127 as mentioned in section 4.6.1, above, and the proposed mechanism of this r.eaction is 





















CHAPTFII4. 5'1<"'£515 OF PROPOS£O ~-H"£MA rJI< JI<HJBJTOHS 
Hydrogen bromide was used to gener~te the key nitrOoonium ion i nterm~diate which fJc il itated 
the conver,ion of the prim.ry <lm i n~ to the di<llOn ium specic,. Presumably the diazonium 
moiety wa, released as nitrogen gas in an 5"' type fashion. to give a st,ble tert i,ry carboc.t ion 
intermedi<ltc. Thi, c<lrbocJtion W<l> then subjected to the nucleophilic attack of the brom ide 
anion. which was generated in 5itu. to fo rm product 36 
Compound 36 was prepared accord ing to the reported 127 procedure ,deviating on ly in 
purification of the crude product by wa,hing it with small quantities of diethyl ether. The 
result ing product was obtilined in a moderate yield (60%), comparable to reported yie lds of 
50%.127 Shifts in the Be NMR spectrum (see figure 4.12) indicil t ed the product obta ined was 
diffe rent f rom the start ing material, 37, and mass spectrometry confirmed the formation of the 
requ ired product which was pure enough to be used in the final coup ling reaction. 
c, 
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Figure 4.12: "c NMR spectra ,howinp, quat""nary carbo1 peak ' hilts of 'tarting moteri" l. compO LJ nd 31ltop) 











CHAPTER 4. SYNTHESIS OF PROPOSED P-HAEMATIN INHIBITORS 
4.6.4 Attempted Grignard reaction between 7-bromo-l,3,5-triazaadamantane, 36, and 
spiro[jluorene-9,2'-oxirane}, 26. 
The final coupling step between compound 26 and 36 to form the proposed compound E 
required the formation of a Grignard reagent from compound 36. The formation of this reagent 
had not been reported in the literature, but the formation of a Grignard reagent from 7-bromo-
adamantane had been described.133-135 The literature preparation described an interesting 
departure from conventional Grignard reaction conditions, demanding no mechanical stirring 
for the successful formation of the Grignard reagent. When stirring was employed, the 
exclusive formation of by-products was observed.135 
While use of this unusual reaction condition in the formation of the adamantyl Grignard 
reagent is well documented, the reasons as to why mechanical stirring has such a pronounced 
effect are not fully understood. Molle et al.135 have undertaken exhaustive investigation into 
this unusual occurrence and from the results obtained have been able provide a possible 
explanation. 
They propose that the Grignard reaction follows the mechanism detailed in scheme 4.13, in 
which the first step involves the adsorption of I-bromo-adamantane (Ad-Br) to the magnesium 
metal and a transient species (Ad··MgBr) is formed. The subsequent formation of the Grignard 
reagent via route ii typically requires the transient species to stay adsorbed to the metal 
surface, while formation of the by-products in routes iii and iv occur upon desorption. In route 
iii, the desorbed transient species reacts with another Ad-Br molecule in solution to produce 
the bi-adamantane (Ad-Ad) side product and in route 4 the transient species reacts with 
solvent molecules (SH) to give side products Ad-H and Ad-S. It was found that mechanical 
stirring of the reaction mixture gave a 70% yield of by-products from route iv and 30% yield of 
by-products from route iii, while with no stirring a yield of 56% of the organomagnesium 



















SYNTHESIS OF PROPOSED ~-HAEMA TIN INHIBITORS 
Ad-MgBr 
Ad--Ad + Mg + MgBr2 
Ad-H + Ad-S-
+ Mg + MgBr2 
Figure 4.13: Proposed mechanism by Molle et 01. 135 for the Grignard reaction of l-bromo-adamantane (Ad-Br). 
Three possible product routes can occur, with route ii leading to the Grignard reagent and routes iii and iv 
leading to by-product formation. Figure adapted from reference 135. 
Molle et 01. 135 concluded that competition between the three possible routes (ii, iii and iv in 
figure 4.13) was dependant on the degree of adsorption of the transient species at the metal 
surface. Because of the large steric volume of the adamantyl molecule, it was assumed that the 
inherent ability of this compound to stay adsorbed to the metal surface was less than other 
haloalkyl compounds. Thus when mechanical stirring was employed, the absorption of the 
transient species formed was further decreased by shearing forces which would release the 
intermediate into the solution. Once in solution, by-products from routes iii and iv would begin 
to form, with the bi-adamantane precipitating from solution and coating the metal surface, 
further shielding adsorption of Ad-Br. 
With this in mind, initial reaction conditions for the formation of the Grignard reagent from 
compound 36 were undertaken with no mechanical stirring. Activated dry magnesium turnings 
(activated by acid wash, followed by water and acetone wash) were added to compound 36 in 
dry diethyl ether, the reaction was gently refluxed and monitored over 19 hours. Samples taken 
from the reaction periodically were added to water and the pH tested. Should a Grignard 
reagent have been present, removal of a hydrogen atom by the Grignard from water would 
have left hydroxide ions in solution resulting in a high pH being obtained. No such pH was 
obtained from the reaction samples, indicating no reaction had occurred. It was then reasoned 
that owing to the insolubility of compound 36 in diethyl ether, a change in solvent system may 
result in the formation of the required Grignard reagent. Dry tetrahydrofuran (THF) was then 











CHAPTER 4. SYNTHESIS OF PROPOSED P-HAEMATIN INHIBITORS 
In order to ascertain whether the Grignard reagent was formed only in small amounts, both 
reaction conditions were repeated with mechanical stirring employed. The rational behind this 
approach was that if the reaction indeed produced the Grignard reagent in small amounts, 
stirring would result in the formation of the by-products detailed in scheme 4.13. Alternatively, 
since this compound had never been reported, there was the possibility that stirring was 
requir.ed to form the product. Unfortunately, NMR spectra taken of the reaction mixture 
showed only starting material with no shifts in the proton or carbon spectra, indicating neither 
formation of the by-product nor the Grignard reagent had occurred. 
It was thus concluded that the formation of the proposed target compound E could not be 
achieved from this synthetic route and the lack of Grignard reagent formation was attributed to 
its insolubility even in the more polar solvent, THF. Perhaps the use of a more polar solvent 
such as dioxane could be used to replace THF. Given the complexity with regard to Grignard 
reagent formation of these types of compounds, it was decided, to abandon the synthesis of 
this proposed compound. 
4.7 Conclusions 
Three of the five proposed compounds (A, Band C) were successfully synthesised and isolated. 
Mass spectrometry indentified the formation of the fourth proposed compound, D, and 
isolation via column chromatography was attempted. Unfortunately owing presumably to low 
yields of the target and large quantities of by-product formation, purification was not 
successful. The fifth proposed compound, E, could not be prepared, seemingly because of 
solubility issues experienced in the final Grignard reaction step. No formation of the required 
Grignard reagent was observed. 
Association constants with haematin and ability to inhibit ~-haematin formation were 

























CHAPTERS. INVESTIGA TlON OF J3-HAEMATIN INHIBITION ACTIVITY BY SYNTHESISED COMPOUNDS 
5.1 Introduction 
The ability to measure ~-haematin (synthetic haemozoin) inhibition has been previously 
investigated utilising a HTS colorimetric assay, developed by Ncokazi and Egan.44 In this assay, 
pyridine added to the reaction mixture selectively coordinates to unreacted Fe(III}PPIX but not 
~-haematin. The former species is present when a compound successfully inhibits ~-haematin 
formation. A bis-pyridyl Fe(III}PPIX complex is formed in the assay that has an absorbance 
maximum at 405 nm. Using UV-vis spectroscopy, the relative quantity of bis-pyridyl Fe(III}PPIX 
can then be determined and from this an ICso for ~-haematin inhibition can be calculated. While 
the conditions employed in this assay are not biological in nature, the ability to screen 
compounds using this technique can identify compounds that have the potential for 
antimalarial activity. 
5.2 p-Haematin inhibition 
Compounds A, 8, C as well as the template compound, 9-hydroxyfluorene, (see figure 5.1) were 
tested for ~-haematin inhibition, according to the modified method of Ncokazi and Egan.44 Over 
the scale of 0 to 10 equivalents of compound relative to Fe(III}PPIX, the range used for the 
detection of strong ~-haematin inhibitors, no activity by any of the compounds was observed. 
Equivalents were increased to 200 (70 in the case of compound A, because of lack of solubility) 
in order to ascertain whether there was any weak inhibiting ability which could perhaps be 
further improved through the modification of aromatic substituents. Unfortunately, no 
inhibition was observed, even at these higher concentrations. 
OH 
A B c 9-hydroxyfluorene 











CHAPTERS. INVESTIGATION OF P-HAEMATIN INHIBITION ACTIVITY BY SYNTHESISED COMPOUNDS 
While the lack of inhibition was unexpected with compound B, which was initially thought to 
possess the required features for inhibiting ability, the inability to inhibit ~-haematin formation 
by the 9-hydroxyfluorene, compound A and negative control, compound C, was expected. In 
the case of 9-hydroxyfluorene, it was hypothesised that the lack of a hydrogen bonding group 
would result in a lack of inhibitory activity and this was confirmed even up to a 200 equivalent 
scale. Modelling showed the hydrogen bonding group of compound A adopted a conformation 
in which it was directed away from the propionate side chain, and thus accounts for its 
inactivity. The negative control, compound C, was through computational modelling, also 
hypothesised to have no activity because of the short one carbon linker which does not provide 
a favourable distance for the primary amine to hydrogen bond to the propionate side chain of 
Fe{III)PPIX (see section 3.5). 
While the inactivity of compounds A, C and the template molecule had been predicted, the 
inability of compound B to prevent formation of ~-haematin was not immediately understood. 
It was reasoned that perhaps the lack of pre-organisation of the hydrogen bonding group, as 
seen in the computational modelling, played a large role in th~ lack of activity. In order to 
obtain better insight into the interactions of these compounds with Fe{III)PPIX, association 
constants for compounds A to C were determined with Fe{III)PPIX 
5.3 Fe(III)PPIX association 
Association constants (log Kobs) for compounds A to C with fe{III)PPIX were determined and 
compared to that of 9-hydroxyfluorene (see table 5.1). It was observed that all the synthesised 
compounds displayed a markedly lower association constant than the template molecule, 
indicating that introduction of the linker chain bearing the hydrogen bond donor at position 9 
of the fluorene ring system caused a decreased association interaction with fe{III)PPIX. In order 
to gain some further understanding of the interactions, pKa values for compounds A to C were 
determined using the MOKA113 software and incorporated into prediction equation 8 (see 
section 2.4) in order to obtain the predicted association constants (log !<calc). Values are 
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Table 5.1. Predicted pKa values and association constants (observed and predicted) for synthesised 
compounds A to C and 9-hydroxyfluorene. 
Compound pKa a Log Kobs Log Kcalc 
b 
9-Hydroxyfluorene 14.33 ± 0.52 3.64 ± 0.09 3.33 ±0.25 
A 15.13 ± 0.52 3.03 ± 0.09 2.98 ± 0.25 
B 15.18 ± 0.52 2.80 ± 0.03 2.97 ± 0.25 
C 14.07 ± 0.52 2.93 ± 0.02 3.30 ± 0.25 
• Predicted using MOKA (reference 113). 
b Calculated using equation 8 (section 2.4) 
Owing to the large errors in predicted pKa values, predicted association constants (log !<calc) are 
not particularly accurate, nevertheless, the trend observ.ed in the calculated pKa values 
uncovered a possible explanation for the lower than expected haematin association constants. 
Comparing the pKa value of 9-hydroxyfluorene to synthesised compounds A and B, it was 
observed that introduction of an alkyl substituent at the 9-position of the fluorene ring system 
caused an increase in pKa of the hydroxyl moiety. This increase in pKa has a detrimental effect 
on Fe(III)PPIX coordination and hence overall association constant under the experimental 
aqueous conditions (pH 7.4) in which association constants are measured, leaving little 
deprotonated species in solution to coordinate to Fe(III)PPIX owing to proton competition. This 
is somewhat confirmed by the fact that the predicted association constants, which take proton 
competition into account, are similar in value to the experimentally obtained association 
constants. 
In the case of compound C, a lower pKa value than 9-hydroxyfluorene was predicted which 
should have resulted in a greater association constant. In fact, the observed association 
constant was as low as compounds A and B, indicating that compound C probably has a similar 
lack of coordinating ability with Fe(III)PPIX. The possible explanation of this lower than 
expected association constant for compound C was attributed to a hypothesised intramolecular 
hydrogen bond between the primary amine and hydroxyl moi.eties (see s.ection 4.5). The 
hydrogen of the hydroxyl moiety is thus less available for deprotonation and this would result 
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5.4 Conclusions 
From these results, it can be concluded that a substituent at the 9-position of the 
9-hydroxyfluorene template is not suitable for designing potential ~-haematin inhibition 
compounds, as introducing the linker bearing the hydrogen bonding moiety at this position 
causes an increase in pKa values of the coordinating hydroxyl group, resulting in a loss of 
coordinating ability in aqueous solution. This results in a lower association with Fe{III}PPIX 
which seemingly does not have a strong enough interaction with Fe{III}PPIX to anchor the 
compound and allow for favourable hydrogen bonding interactions, thus resulting in an inability 























CHAPTER 6. CONCLUSIONS AND FUTURE WORK 
6.1 Conclusions 
The aims of this project were to investigate coordination and IT-stacking interactions with the 
target compound Fe(lIl)PPIX in order to optimise these underlying interactions together with 
hydrogen bonding in order to propose potential novel l3-haematin formation inhibitors. These 
proposed compounds were then to be synthesised and activity against j3-haematin formation 
tested to provide evidence for a hypothesised mechanism of action. 
Investigation of coordination and n-stacking with Fe(III)PPIX provided useful insight into such 
interactions. Coordination is simply cktermined by basicity of the donor atom, while IT-stacking 
is largely determined by the number of IT-electrons in the aromatic ring. The results obtained 
from these investigations provided a .general LFER equation which can be used to predict 
moderately accurate association constants of many small compounds with Fe(III)PPIX. This has 
provided a platform for the identifk:ation of novel scaffold molecules that can be further 
developed into l3-haematin inhibitors. 
Unfortunately, whHe identification of moderately strong Fe(III)PPIX associating molecules is 
seemingly a fairly trivial exercise, developing these scaffolds into l3-haematin inhibitors, through 
incorporation of hydrogen bonding moieties, remains a challenge. This was observed in the 
current study where none of the three successfully synthesised compounds proposed as 
l3-haematin inhibitors (compounds A, Band C) were in fact unable to inhibit j3-haematin 
formation. Fortunately, a possible reason behind the inactivity of the compounds could be 
proposed, namely that of increased pKa of the hydroxyl group upon substitution at the 9 
position of the scaffold 9-hydroxyfluorene ring system which decreases the coordinating ability 
to the iron centre of Fe(III)PPIX. While the synthesised compounds are unable to inhibit 13-
haematin formation, the findings of this study suggest that the effect of substitutions on the 
pKa of the coordinating group will need to be taken into account when designing further 13-
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6.2 Future work 
Understanding interactions with Fe(III)PPIX is paramount for the rational design of ~-haematin 
inhibitors and while this study has uncovered some information about two interactions, 
coordination and 1t-stacking, there remain areas that require further investigations. Firstly, a 
study on the effects of differing aromatic substituents and positions on 1t-stacking interactions 
with Fe(III)PPIX would prove an informative endeavour, as substituents that provide for 
favourable interactions could be incorporated into the template ring system. This would result 
in stronger interactions with Fe(III)PPIX which would provide for a more suitable anchor moiety 
onto which hydrogen bonding groups can be attached to interact with the propionate side 
chain and hence potentially inhibit ~-haematin formation. Substituted benzoic acids, benzyl 
alcohols and pyridines are just some of the commercially available compounds that could be 
tested with Fe(III)PPIX in a similar study to that reported here, so as to provide insight into 
these effects. Secondly, a more detailed investigation into the enhanced associating ability of 
4-aminoquinolines with Fe(III)PPIX is required, focusing primarily on charge-charge and cation-1t 
interactions. By having a better understanding of these interactions, compounds can be 
proposed with a greater potential for inhibiting ~-haematin formation. 
While none of the three proposed compounds in this study which were successfully synthesised 
and isolated (A, Band C) were able to inhibit l3-haematin formation, the scaffold molecule, 
9-hydroxyflourene, remains of interest owing to its relatively strong association with Fe(III)PPIX. 
The findings of this work suggest that incorporation of the linker containing the hydrogen 
bonding group at the 9-position of the ring system is detrimental to coordination interactions. 
This could be possibly be alleviated by substitution of this moiety on the fluorene aromatic ring 
system instead. As an alternative to aromatic methanols, thought should be given to amine 
moieties as potential iron coordinators. As seen from this study, primary amines that can both 
coordinate and 1t-stack are not suitable as scaffold molecules probably because the preferred 
conformations results in only one of these interactions with Fe(III)PPIX occurring, nevertheless, 
by substituting bulky groups on the carbon adjacent to the amine, the conformation could 
possibly be locked to provide the geometry necessary for simultaneous coordination and 























CHAPTER 7. EXPERIMENTAL METHODOLOGIES 
7.1 Physicochemical methods 
7.1.1 Genera/. 
Unless otherwise stated, all compounds were purchased from Sigma-Aldrich and were of 
analytical grade. With the exception of imidazole and quinoline, they were used without further 
purification. Imidazole was recrystalised from toluene, while quinoline was vacuum distilled at 
125°C. Haemin was obtained from Fluka and used as received. Spectrophotometric titrations 
were recorded on Varian Cary 100 UV-vis spectrophotometer (manufacturer specifications 
report linearity up to 3 aufs) with quartz cuvettes of 1 cm path length. Temperature was 
maintained at 25.0 ± 0.2 °c throughout by means of a thermostatted water bath. Aliquots of 
ligand solutions were delivered into cuvettes using a Hamilton syringe, except in the case of 5-
methylphenanthroline where Gilson pipettes were used as complexation to free metal in the 
Hamilton syringe was observed. Cuvettes were scrupulously washed with 0.2 M NaOH, followed 
by rinsing with water, then addition of 1 M HN03 and a final water rinsing, as previously 
described by Asher et a/.104, to avoid a buildup of adsorbed Fe(III)PPIX and PPIX. 
7.1.2 Beers law studies. 
Haematin (2 x 10-4 M, 20% (v/v) DMSO in methanol) and PPIX (1 x 10-4 M in DMSO) were 
titrated into the solvent systems of interest. Final composition of DMSO added in 40% (v/v) 
aqueous DMSO solvent system was 41.6%. 
7.1.3 Spectrophotometric titrations. 
Titrations with Fe(III)PPIX under aqueous DMSO 'Conditions were carried out as detailed 
previously,75,84 deviating only in the use of a 1 x 10-5 M Fe(III)PPIX working solution. Titrations 
under organic conditions (20% DMSO in methanol) were carried out by preparing a stock 
solution of haematin (1 x 10-3 M in DMSO) which was then diluted to give 1 x 10-5 M in a 20% 
DMSO in methanol solution. Titrations with PPIX under aqueous conditions were carried out as 
for aqueous Fe(III)PPIX titrations but a stock solution of PPIX (6 x 10-4 M in DMSO) was used and 
diluted to give a working solution concentration of 3 x 10-6 M in 40% (v/v) aqueous DMSO. All 
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Solutions of compounds tested were made up and pH corrected to 7.4, with concentrations 
ranging from 5 x 10-3 M to 2 M, depending on the strength of association with Fe(III)PPIX or 
PPIX and its solubility. Data obtained were corrected for dilution and analysed using non-linear 
least squares fitting methods at Amax (400 and 402 nm for Fe(III)PPIX and PPIX, respectively). 
Equations 2, 3 and 4 were considered in each case and the best fit was chosen. Titrations were 
performed in triplicate to give an average association constant and are reported with the 




A = Ao + A",K[L] 
l+K[L] 
A = Ao + Al Kl [L] + A",K1 K2 [L]2 
1 + Kl [L] + Kl KJL]2 





Where K is the association constant, [L] is the free ligand concentration which in the case of 
weak association is approximately the concentration of ligand added, A is the observed 
absorbance, Ao the initial absorbance, Al the absorbance of the intermediate (in the case of 2:1 
stepwise complex) and Aoo is the absorbance of the final complex formed in the presence of a 
very large excess of ligand. 
7.1.4 pKa determination. 
A 9-aminofluorene hydrochloride solution (1 mM in water) was titrated with a 0.1 M NaOH 
solution and the pH measured after each addition using a glass electrode on a Crison MicropH 
2000 pH meter. Data were analysed by a non-linear regression to give a measured pKa. 
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7.1.5 Molecular mechanics and dynamics (with simulated annealing) modelling. 
Modelling of compounds bound to the iron centre of Fe(III)PPIX was performed using 
HYPERCHEM136• The force field employed was based on that of Allinger137 as modified by 
Marques and co-workers138, 139 for metalloporphyrins and further parameterised for 
metalloporphyrin-alkoxide interactions.76 Proposed compounds were built in HYPfRCHEM 
containing a protonated terminal hydrogen bond donor and Fe(III)PPIX was built with both 
propionate side chains deprotonated. Proposed compounds were then bonded to the iron 
centre of Fe{III)PPIX through the alkoxide group and geometry optimisation performed using 
molecular mechanics. In order to obtain the lowest energy conformation of the complex, 
molecular dynamics were then preformed with simulated annealing. Trajectories were 
calculated at a run time of 100 ps at 1000 K. For each complex, 1000 snapshots were recorded 
and simulated annealing (from 1000 to 0 Kover 20 ps) of everY 10th snapshot was performed. 
The snapshot with the lowest energy conformation was then identified, and an intramolecular 
hydrogen bonded conformation between the hydrogen bond donor and propionate group was 
constrained using a dummy bond with a force constant of 100 000 mdyne/ A. Molecular 
mechanics were performed on this complex, after which the dummy bond was removed and 
further mechanics performed to optimise geometry. The single point energy of this 
conformation was compared to that of the lowest energy conformation. An energy surface map 
of compound E bound to Fe{III)PPIX was determined using the method reported by de Villiers et 
al.76 The conformational strain energy as the complex was rotated (in 30°C increments) around 
bonds, N2-Fe(III)-O(87)-C(74) and C(76)-C(24)-C(88)-C(89), defined as 4> and lIJ respectively, was 
measured. Plotting 4> vs lIJ produced the energy surface for the complex. 
7.1.6 p-Haematin inhibition. 
p-Haematin inhibition tests were carried out by modifying the pyridine colorimetric assay 
developed by Ncokazi and Egan.44 The original procedure required the use of a 12.9 M acetate 
buffer (pH 4.8) but because of difficulties solubilising acetate, the concentration was lowered to 
9.7 M (pH 4.8) and volumes of reagents adjusted accordingly. This less concentrated buffer was 
made by adding sodium acetate (47.5 g) to acetic acid (35.5 ml) and diluted to 100 ml with 
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Serial dilutions of compounds in a 96 well plate were made by placing 20 III of a stock solution 
(0.168 M) in the first well and 10 III of solvent in the remaining wells. Removal of 10 III from the 
first well and mixing into the second well provide a 1 in 2 dilution, and this was then repeated 
down the plate to give compound:Fe(III)PPIX rations of 10, 5, 2.5, 1.25, 0.625, 0.313 and 0.1'56 
mole equivalents as well as a control with no compound added. To tnis, 83.6 III of haematin 
(2.03 x 10-3 M in 0.1 M NaOH), 8.4 III HCI (1 M) and 78 III acetate buffer (9.7 M) were added to 
each well and mixed. The plate was incubated for 60 minutes at 60°C after which the wells 
were quenched by addition of 80 III of 30% (v/v) aqueous pyridine solution (2 x 10-2 M HEPES, 
pH 7.5) and allowed to settle. Once settled, 38 III of the supernatant was removed and placed 
in another 96 well plate. These were diluted with 250 III of the aqueous pyridine solution, 
absorbances read at 405 nm and the data obtained fitted to a sigmoidal dose response model. 
7.2 Synthesis 
7.2.1 General. 
All chemicals and solvents were purchased from Sigma-Aldrich and, un~ss otherwise stated, 
used as received. Tetrahydrofuran and diethyl ether were distilled under a nitrogen 
atmosphere and dried over sodium wire with benzophenone. Oichloromethane was distilled 
under nitrogen atmosphere and dried over phosphorous pentoxide. Reactions were monitored 
by thin-layer chromatography (TlC) using pre-coated silica-gel 60 f 254 (0.2 mm) mounted on 
aluminium-backed plates, commercially available from Merck. Compounds were detected using 
UV absorption (254 nm) and spray reagents anisaldehyde and ninhydrin, prepared according to 
Iiterature.140 Column chromatography was condu<:ted using Merck Kieselgel 60 silica gel. Flash 
chromatography was performed using a Supleo VersaFlush. 
Nuclear magnetic resonance spectra were recorded on either a Varian Unity 400 (at 399.95 
MHz for IH and 100.58 MHz of BC) or Varian VXR-300 (at 300.08 MHz for IH and 75.5 MHz for 
BC). Solvents used were d-COCI3, d6-OMSO, d4-(0300 and 020 with residual peaks occurring at 
7.26, 2.50, 3.31 and 7.79 ppm in IH NMR and 77.16, 39.52 and 49.00 ppm in BC NMR, 
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Infrared (IR) spectra were recorded on a Perkin-Elmer Paragon 1000 FT-IR spectrophotometer, 
using potassium bromide plates. Elemental analysis (EA) was performed using a Fisons EA 1108 
CHN elemental analyser. Melting points were determined using a Reichert Jung Thermovar hot-
stage microscope. Electron ionisation (EI) mass spectrometry was recorded on a JEOL GCmate II 
at the Department of Chemistry, University of Cape Town and high resolution mass 
spectrometry (HRMS) was recorded on an API Q-TOf Ultima machine at The School of 
Chemistry, University of Stellenbosch. 
7.2.2 4-Quinonline methanol, 22. 
To a solution of 4-quinoline carboxaldehyde (0.158 g, 1.00 mmol) in ethanol (15 ml), sodium 
borohydride (0.077 g, 2.04 mmol) was added slowly at room temperature. The reaction was left 
stirring for 1.5 hours after which TLC (MeOH/DCM, 5:95, Rf = 0.29) indicated no starting 
material remained. Et20 (25 ml) was then added, followed by washing with water (2 x 25 ml). 
Aqueous washings were combined and extracted with Et20 (2 x 50 ml). All organic fractions 
were then pooled, dried over magnesium sulfate, filtered and the filtrate evapourated under 
reduced pressure. The resulting brown crystals obtained were recrystalised using Hex/EtOAc to 
give white crystals identified as compound 22 (0.037 g, 67%) by NMR spectrometry. 
m.p. 91-93 °c (Lit:114 99-100 0C). lH NMR (400 MHz, d-CDCI3): liH 5.24 (2H, s, H-ll), 7.55 (2H, m, 
H-3 and -7), 7.72 (lH, t, J = 7.1 Hz, H-8), 7.96 (lH, d, J = 8.3 Hz, H-9), 8.13 (lH, d, J = 8.4 Hz, H-6), 
8.84 (lH, d, J = 4.4 Hz, H-2); 13C NMR (100 MHz, d-CDCh): lie 61.4 (C-ll), 118.2 (C-3), 122.9 
(C-6), 125.9 (C-4), 126.7 (C-7), 129.3 (C-9), 129.9 (C-8), 146.5 (C-5), 147.7 (C-I0), 150.3 (C-2). MS 
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7.2.3 Spiro(fluorene-9,2I-oxirane},26. 
5 4 
To sodium hydride (60% oil immersion, 0.266 g, 6:65 mmol) in dry DMSO (5 ml), 
trimethylsulfoxonium iodide (1.47 g, 6.72 mmol) was slowly added and the mixture left to stir 
at room temperature for 30 minutes. 9-Fluorenone (0.989 g, 5.49 mmol) was then slowly added 
and the reaction mixture left to stir for a further 1.5 hours, after which TlC (EtOAc/Hex, 5:95, 
Rf = 0.45) indicated no starting material remained. Ice water (10 ml) was added to quench the 
reaction and an extraction with Et20 (2 x 15 ml) followed. Organic layers were washed with cold 
water (2 x 30 ml), dried over MgS04, filtered and the filtrate reduced under vacuum at 25 Dc. 
The resulting yellow/white solid obtained was identified as the epoxide 26 (0.672 g, 98% crude) 
and was used in its impure form in subsequent reactions. m.p. 56-58 DC (lit:142 108-110 DC). 
lH NMR (300 MHz, d-CDCI3): eSH 3.71 (2H, s, H-2'), 7.27 (4H, m, H-2, -4, -5 and -7), 7.43 (2H, t, 
J = 7.0 Hz, H-3 and -6), 7.73 (2H, d, J = 7.5 Hz, H-1 and -8); 13C NMR (100 MHz, d-CDCh): eSc 54.9 
(C-2'), 62.3 (C-9), 120.4 (C-4 and -5), 121.7 (C-1 and -8), 127.6 (C-2 and -7), 129.4 (C-3 and -6), 
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7.2.4 9-Hydroxy-fluorene-9-acetonitrile, 25. 
7 
5 4 
To crude spiro[fluorene-9,2'-oxirane] (2.50 g, 12.5 mmol) in methanol (32 ml), sodium cyanide 
(3.15 g, 154.3 mmol), ammonium chloride (2.08 g, 38.8 mmol) and water (4 ml) were added at 
room temperature. The mixture was left to stir overnight (14 hours) at 25°C, after which TlC 
(EtOAc/Hex, 20:80, Rf = 0.26) indicated no starting material remained. The mixture was then 
diluted with water (24 ml), extracted with Et20 (3 x 50 ml), washed with water (2 x 100 ml) and 
the organic layers dried over MgS04• After filtration, the filtrate was reduced under vacuum and 
the resulting orange oil purified using column chromatography (Si02, EtOAc/Hex, 10:90 to 
20:80) to give the compound 25 as a white solid (1.58 g, '65% over 2 steps). m. p. 93-95 °c 
(Ut:143 97.5-98.5 0C). Vmax /cm-
1 (KBr): 3340b (O-H), 3066w + 3044w (C-H, aromatic), 2957m + 
2928m (C-H, aliphatic), 2257m (CN, nitrile), 1607m (C=C, aromatic); lH NMR (400 MHz, 
d-CDCI3): liH 2.34 (lH, bs, OH), 2.98 (2H, s, H-14), 7.38 (2H, t, J = 7.3 Hz, H-2 and -7), 7.46 (2H, t, 
J = 7.4 Hz, H-3 and -6), 7.67 (2H, d, J = 7.4 Hz, H-4 and -5), 7.73 (2H, d, J = 7.2 Hz, H-l and -8); 13C 
NMR (400 MHz, d-CDCh): lie 29.4 (C-14), 78.1 (C-9), 116.7 (C-15), 120.4 (C-4 and -5), 123.6 (C-l 
and -8), 128.5 (C-2 and -7), 130.1 (C-3 and -6), 139.0 (C-11 and -12), 145.9 (C-l0 and -13). MS 
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7.2.5 9-(2-Aminoethyl)-fIuoren-9-01, A. 
5 4 
To (9-hydroxy-9H-fluoren-9-yl)acetonitrile (0.73 g, 3.32 mmol) in dry Et20 (20 ml) at 0 °c, 
lithium aluminium hydride (0.25 g, 6.64 mmol) was slowly added. The reaction mixture was 
then left to warm to a temperature of roughly 10°C over 2 hours, after which, the temperature 
was increased to 25 °c and the reaction mixture left for 22 hours. TLC (EtOH/OCM, 10:90, 
Rf = baseline) indicated no starting material remained and so NaOH (2 M, 10 ml) was slowly 
added at 0 0c. The organic layer was separated and n extraction of the aqueous layer with 
OCM (3 x 20 ml) followed. All organic fractions were combined, washed with water {l x 40 ml), 
dried over MgS04 and filtered. The filtrate was then reduced under vacuum to give a yellow oil. 
This was purified using flash chromatography (MeOH/OCM, 0:100 to 15:85) and the tan 
coloured oil obtained washed with Et20 to give a white solid identified as the amine (0.51 g, 
68%). m. p. lOS-107°C. vmax /cm-
1 (KBr): 3340b (OH), 3054w (C-H, aromatic), 2985m + 2931m 
(C-H, aliphatic), 1265s (C-N, amine); lH NMR (300 MHz, d-COCI3): BH 2.03 (2H, t, J = 7.3 Hz, 
H-14), 2.68 (2H, t, J = 7.4 Hz, H-15), 7.19 -7.32 (4H, m, H-2, -3, -6 and -7), 7.45 (2H, d, J = 7.4 Hz, 
H-4 and -5), 7.54 (2H, d, J = 7.3 Hz, H-l and -8); 13C NMR (100 MHz, d-COCI3): Be 38.0 (C-14), 
44.0 (C-15), 82.1 (C-9), 119.9 (C-4 and -5), 123.8 (C-1 and -8), 127.8 (C-2 and -7), 128.7 (C-3 and 
-6), 139.1 (C-11 and -12), 149.0 (C-I0 and -13). HRMS (ESI): found 226.1248 ([M+Ht). C1sH1SNO 
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7.2.6 1-[2-(9-Hydroxy-jluoren-9-y/)ethy/]guanidinium nitrate, B. 
7 
2 
To 9-{2-aminoethyl)-9H-fluoren-9-01 (0.22 g, 0.99 mmol) in methanol (8 ml), 3,5-dimethyl-
pyrazole-l-carboximidamidium nitrate (0.20 g, 0.99 mmol) was added and the mixture left to 
reflux for 14 hours. TlC (MeOH/DCM, 10:90, Rf = 0.16) showed product formation and no 
starting material remaining. The reaction mixture was concentrated under reduced pressure 
and the resulting tan oil was subjected to flash chromatography (Si02, EtOH/MeOH/DCM, 
5:0:95 to 0:10:90). The clear oil obtained still contained impurities and so was subjected to 
further column chromatography (Si02, MeOH/DCM, 0:100 to 5:95 and then EtOH/DCM, 0:100 
to 15:85) resulting in the isolation of the pure guanidine product in the form of a white solid 
(0.21 g, 64%). m. p. ISO-153°C. Vmax /cm-
1 (KBr): 3342b (OH), 2964m + 2920m (C-H, aliphatic), 
1665s (C=N, guanidine). IH NMR (400 MHz, d4-CD30D): BH 2.36 (2H, t, J = 7.2 Hz, H-14), 3.02 
(2H, t, J = 7.8 Hz, H-15), 7.34 (2H, t, J = 7.2 Hz, H-2 and -7), 7.39 (2H, t, J = 7.3 Hz, H-3 and -6), 
7.55 (2H, d, J = 6.9 Hz, H-4 and -5), 7.71 (2H, d, J = 7.6 Hz, H-l and -8); 13C NMR (lOO MHz, 
d4-CD30D): Be 39.7 (C-14), 40.4 (C-15), 82.4 (C-9), 121.9 (C-4 and -5), 125.4 (C-l and -8), 129.8 
(C-2 and -7), 130.9 (C-3 and -6), 141.5 (C-ll and -12), 150.2 (C-I0 and -B), 159.0 (C-16). HRMS 
(ESI): Found 268.1443 ([M+Ht). C16H17N30 requires 267.327 ([M]). Anal. Calcd for 
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7.2.7 9-[(TrimethylsilyIJoxyJ-fluorene-9-carbonitrile, 30. 
TMSO 
5 4 
To a mixture of fluorenone (1.98 .g, 11.0 mmol) and iodine (0.14 .g, 0.6 mmol) in dry OCM 
(50 ml) under nitrogen atmosphere, trimethylsilyl cyanide (2 ml, 14.9 mmol) was slowly added 
at 0 0c. The reaction was then left to stir at room temperature for 2 hours, after which TLC 
(EtOAc/Hex, 10:90, Rf = 0.54) indicated no starting material remained. The reaction mixture was 
then quenched with water (50 ml) and extracted with OCM (2 x 50 ml). Organic layers were 
pooled, wastH!d with 15% sodium thiosulfate (100 ml) and dried over sodium sulfate. This was 
then filtered and the filtrate removed under reduced pressure to give yellow/white crystals. 
These were washed with hexane to give product 30 (0.836 g, 27%) as white crystals in high 
purity. m.p. 91-93 °c (Lit:120 98-100 0C). vmax /cm-1 (KBr): 3080m to 3012m (C-H, aromatic), 
2964s + 2902m (C-H, aliphatic), 2238s (CN, nitrile); lH NMR (300 MHz, d-CDCI3): eSH 7.39 (2H, t, 
J = 7.5 Hz, H-2 and -7), 7.47 (2H, t, J = 7.5 Hz, H-3 and -6), 7.65 (2H, d, J = 7.4 Hz, H-4 and -5), 
7.73 (2H, d, J = 7.5 Hz, H-1 and -8); 13C NMR (100 MHz, d-COCI3): eSc 1.3 (TMSO), 53.4 (C-9), 
120.2 (C-14), 120.6 (C-4 and -5), 125.5 (C-1 and -8), 128.8 (C-2 and-7), 131.0 (C-3 and -6), 139.6 
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7.2.8 9-(Azidomethyl)-/luoren-9-o1, 31. 
5 4 
To a mixture of spiro[fluorene-9,2 1-oxirane] (2.03 g, 10.4 mmol) and ammonium chloride 
(1.50 g, 28.1 mmol) in MeOH/H20 (8:1, 27 ml), sodium azide (3.09 g, 47.5 mmol) was added and 
the mixture left to stir at room temperature for 16 hours. TLC (EtOAc/Hex, 20:80, Rf = 0.29) 
indicated no starting material remained, so water (23 ml) was added to the reaction mixture 
and an extraction with Et20 (2 x 50 ml) followed. Organic layers were washed with water 
(2 x 100 ml) and dried over MgS04. After filtration, the filtrate was reduced under vacuum to 
give a pale yellow oil identified as the azide 14 (2.43 g, 98%) which was pure enough to be used 
in subsequent reactions. Vmax /cm-
1 (Thin layer): 3392b (O-H), 3058w (C-H, aromatic), 2924w 
(C-H, aliphatic), 2106s (N3, azide), 1607w (C=C, aromatic); lH NMR (400 MHz, d-CDCI3): OH 3.85 
(2H, s, H-14), 7.38 (2H, t, J = 7.5 Hz, H-2 and -7), 7.47 (2H, t, J = 7.5 Hz, H-3 and -6), 7.64 (2H, d, 
J = 7.5 Hz, H-4 and -5), 7.73 (2H, d, J = 7.5 Hz, H-1 and -8); 13C NMR (100 MHz, d-CDCI3): 6c 65.8 
(C-9), 68.0 (C-14), 120.4 (C-4 and -5), 124.7 (C-1 and -8), 128.1 (C-2 and -7), 129.8 (C-3 and -6), 
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7.2.9 9-(Aminomethyl)-fluoren-9-o1, C. 
7 
5 4 
To 9-{azidomethyl)-f1uoren-9-01 (0.37 g, 1.56 mmol) in a MeCN/H20 (16 ml, 7:1) solution, 
triphenylphosphine (0.49 g, 1.88 mmol) was added and the mixture left to stir at room 
temperature for 14 hours. T.LC (MeOH/DCM, 5:95, Rf = 0.41) indicated no starting material 
remained and so the reaction mixture was concentrated under reduced pressure and the 
resulting dark brown oil purified using column chromatography (Si02, MeOH/DCM, 1:99 to 
5:95). To the yellow oil obtained, H 20 was slowly added which caused precipitation of a white 
solid. The solid was filtered, washed with Et20 and kept aside. Washings were reduced under 
vacuum and the procedure repeated again to give more white precipitate. All solid was pooled 
and identified as the amine C (0.21 g, 64%). m.p. 117-118 °c {Lit:144 134-135 0q. lH NMR (300 
MHz, d-CDCI3): eSH 2.43 (3H, bs, -OH and -NH2), 3.70 (2H, s, H-14), 7.30 (2H, t, J = 7.4 Hz, H-2 and 
-7), 7.38 (2H, t, J = 7.4 Hz, H-3 and -b), 7:58 (2H, d, J = 7.7 Hz, H-4 and -5), 7.68 (2H, d, J = 7.5 Hz, 
H-l and -8); 13C NMR (100 MHz, d-CDCI3): eSc 65.8 (C-9), 69.2 (C-14), 120.1 (C-4 and -5), 123.8 
(C-l and -8), 127.7 (C-2 and -5), 128.6 (C-3 and -6), 139.6 (C-ll and -12), 148.8 {C-I0 and -13). 
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7.2.10 Formamidinesulfonic acid, 33. 
Formamidinesulfinic acid (2.00 g, 18.5 mmol) in acetic acid (6 ml), was chilled to roughly 10°C 
and peracetic acid (4.8 ml, 25.4 mmol) slowly added so as to maintain the temperature under 
20°C. After addition, the reaction was left to stir at roughly 15 °c for 1 hour and room 
temperature for 2 hours. The precipitate formed was filtered and washed with ethanol to give 
formamidinesulfonic acid as a white solid (1.84 g, 80%). Vmax /cm·
1 (KBr): 3353b and 3129b 
(N-H), 1688s (C=N), 1228s and 1054m (S03H). MS (EI): found 125.5359 ([M+Ht). CH4N20 3S 
requires 124.1191 ([M]). 
7.2.11 7-Nitro-l,3,S-azaadamantane, 38: Method a. 
9 
N~~N 




To a solution of hexamethylenetatramine (14.02 g, 0.10 mol) and glacial acetic acid (6.25 ml, 
0.12 mol) in n-butanol (15 ml), nitromethane (6.5 ml, 0.12 mol) was slowly added at room 
temperature. The mixture was left to reflux at 109°C for 4 hours after which TlC (MeOH/DCM, 
10:90, Rf = 0.50) indicated no starting material remained and the resulting precipitate was 
filtered. A recrystaHsation from water produced a dark brown solid which floated on the surface 
of the water and a tan colour solid which lay on the bottom of the recrystalisation vessel. The 
tan coloured crystals were collected and identified as compound 38 (2.21 g, 12%) by NMR and 
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7.2.12 7-Nitro-l,3,S-azaadamantane, 38: Method b. 
To a solution of hexamethylenetatramine (10.00 g, 71.3 mmol) in glacial acetic acid (10 ml, 
184.0 mmol), nitromethane (4.25 ml, 79.1 mmol) was slowly added at room temperature. The 
mixture was left to reflux at 95°C for 6 hours, after which the resulting precipitate was fHtered 
and washed with copious amounts of water. The precipitate was collected and dried under 
vacuum to give tan crystals of product 7 (13.1 g, 53%) which were deemed pure enough for 
subsequent reactions. m.p. 183-185 °c (Lit:130 260-310 0q. lH NMR (300 MHz, 020): OH 3.82 
(6H, s, H-6, -8, -10), 4.10 (3H, d, J = 6.0 Hz), 4.43 (3H, d, J = 12.9 Hz); 13C NMR (100 MHz, 020): Oc 
57.4 (C-6, -8, -10), 70.9 (C-2, -4, -9), 72.8 (C-7). MS (EI): Found 184.0449 ([Mt). C7H12N402 








To 7-nitro-1,3,5-azaadamantane (23.17 g, 126.0 mmol) and Raney Nickel (50% in water, 3.59 g) 
in a water/isopropanol (14:1, 34 ml) solution, hydrazine monohydrate (0.6 ml, 12.37 mmol) was 
slowly added in portions over a 1 hour period. Upon completion of addition, the reaction 
mixture was left to stir at room temperature for an hour after which another portion of Raney 
Nickel (1.01 g) in a water/isopropanol mixture (14:1, 2 ml) was added. The reaction left to stir 
for a further 2 hours after which TLC (MeOH/OCM, 10:90, baseline) indicated no starting 
material remained. The mixture was then filtered to remove Raney Nickel, washed with 
isopropanol and the filtrate reduced under vacuum to give the hygroscopic tan coloured solid 
37 (11.83 g, 61%). m. p. 139-144 °c (dec.). (Lit:127 295-297 0q lH NMR (400 MHz, 020): OH 3.15 
(6H, s, H-6, -8, -10), 3.98 (3H, d, J = 12.1 Hz), 4.33 (3H, d, J = 12.5 Hz); 13C NMR {400 MHz, 020): 
Oc 38.4 (C-7), 61.4 (C-6, -8, -10), 70.9 (C-2, -4, -9). MS (EI): Found 154.0955 ([Mt). C~14N4 



















To 7-amino-l,3,5-azaadamantane (0.99~, 6.45 mmol) suspended in aqueous hydrogen bromide 
(48%, 4.6 ml) at 0 °c, sodium nitrite (0.55 g, 7.93 mmol) was slowly added over 30 minutes. 
Once addition was completed, the r.eaction was allowed to gradually reach room temperature 
and was left to stir for 3 hours. Potassium carbonate was then added to the r.eaction mixture 
until effervescence ceased (ca. pH 8) and an extraction with OCM (3 x 40 ml) followed. The 
organic layers (top layers) were pooled, dried with MgS04, filtered and the filtrate reduced 
under vacuum. The resulting yellow solid obtained was then washed with Et20, filtered and 
kept aside. The filtrate was collected, reduced and washing repeated twice more. All solid 
material obtain.ed was combined to give the bromide 36 (0.84 g. 60%). m. p. > 295°C (Lit:127 
217-219 0C). lH NMR (300 MHz, 020): eSH 3.79 (fiH, s, H-6, -8, -10), 4.26 (3H, d, J = 11.6 Hz), 4.51 
(3H, d, J = 12.8 Hz); 13C NMR (100 MHz, 020): eSc 57.7 (C-7), 65.5 (e-6, -8, -10), 73.1 (C-2, -4, -9). 
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